{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":51,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":51,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"5ce50c55e25f","filters":{"venue":"Immunotherapy"}},"results":[{"id":"W2156823146","doi":"10.2217/imt.13.123","title":"Evolution of Oncolytic Viruses: Novel Strategies for Cancer Treatment","year":2013,"lang":"en","type":"review","venue":"Immunotherapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":57,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"","keywords":"Oncolytic virus; Biology; Immune system; Cancer; Virotherapy; Immunotherapy; Virus; Immunology; Immunogenic cell death; Innate immune system; Virology; Cancer research; Genetics","authors":[{"name":"Matthew J. Atherton","is_ca":true},{"name":"Brian D. Lichty","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08584175302475491,"gpt":0.4154220359967364,"spread":0.3295802829719815,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001613656,0.0004351244,0.000948109,0.0001190405,0.00006744268,0.00004333485,0.0004041489,0.0003943887,0.00008244532],"category_scores_gemma":[0.000008186441,0.0003280861,0.0006495896,0.000134368,0.0001187341,0.000006121957,0.00002844532,0.00009133479,0.00001514951],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003610316,"about_ca_system_score_gemma":0.002242957,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004623945,"about_ca_topic_score_gemma":0.0002964318,"domain_scores_codex":[0.9984601,0.00009035716,0.0004965474,0.0004437939,0.0001593643,0.0003498101],"domain_scores_gemma":[0.9986969,0.00004574406,0.0003415249,0.0007026517,0.0001660287,0.00004717119],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005705294,0.000235764,9.625696e-7,0.001348786,0.001108856,1.705473e-7,0.00003569581,0.00002532735,0.1172169,0.0001206516,0.0002132078,0.8791231],"study_design_scores_gemma":[0.001242481,0.004723688,7.545962e-7,0.0007353289,0.0001311512,0.000003335139,0.00003682488,0.00001305123,0.007580205,0.00004199507,0.9851753,0.0003159499],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001564984,0.9941537,0.00122356,0.000007977485,0.0001858661,0.002368989,0.0004085792,0.00001270922,0.00007366853],"genre_scores_gemma":[0.0001203877,0.9950554,0.0003117101,0.00003393976,0.0003475514,0.002826702,0.0001660984,0.0001221039,0.00101614],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.984962,"threshold_uncertainty_score":0.9999171,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2135975326","doi":"10.2217/imt.14.66","title":"Vedolizumab for Ulcerative Colitis and Crohn’s Disease: Results and Implications of GEMINI Studies","year":2014,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Vedolizumab; Ulcerative colitis; Medicine; Inflammatory bowel disease; Internal medicine; Gastroenterology; Crohn's disease; Placebo; Maintenance therapy; Disease; Immunology; Pathology; Chemotherapy","authors":[{"name":"Mindy Lam","is_ca":true},{"name":"Brian Bressler","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01453315354671545,"gpt":0.2979342926323513,"spread":0.2834011390856359,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001248853,0.00009397732,0.000110492,0.00001825046,0.0000906098,0.00001231167,0.00005978471,0.00003990061,0.000001158285],"category_scores_gemma":[0.0001751784,0.00008705756,0.00003699022,0.00001715847,0.0001847809,0.000003556014,0.00002954743,0.00001850769,3.487411e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000006719672,"about_ca_system_score_gemma":0.00003763902,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002784777,"about_ca_topic_score_gemma":0.00001735522,"domain_scores_codex":[0.9994496,0.00004282413,0.0001631644,0.000200792,0.00003623172,0.0001074363],"domain_scores_gemma":[0.9994179,0.00004595405,0.0001028117,0.0002539555,0.0001310578,0.00004830934],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.06041318,0.0005824985,0.04063427,0.001111558,0.002691937,0.0000190012,0.006897938,0.00005543164,0.5340439,0.06962138,0.02054527,0.2633836],"study_design_scores_gemma":[0.002336478,0.0001477594,0.9719377,0.00002134668,0.00002052968,0.000001901184,0.00009302868,0.00003322182,0.00380953,0.001667734,0.01980391,0.0001268807],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9953609,0.002973344,0.0004337084,0.0003462658,0.00003903381,0.0003618487,0.000309117,0.000007177654,0.0001686126],"genre_scores_gemma":[0.9969239,0.001808498,0.0004447185,0.000239629,0.00007481848,0.0001408611,0.00005984866,0.00001541759,0.0002922684],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9313034,"threshold_uncertainty_score":0.3550104,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2133116144","doi":"10.2217/imt.09.40","title":"Immunotherapy as a Strategy for Treatment of Leishmaniasis: a Review of the Literature","year":2009,"lang":"en","type":"review","venue":"Immunotherapy","topic":"Research on Leishmaniasis Studies","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"Canadian Institutes of Health Research; Manitoba Health Research Council","keywords":"Leishmaniasis; Medicine; Immunotherapy; Immunology; Intensive care medicine; Drug resistance; Drug; Immune system; Biology; Pharmacology","authors":[{"name":"Ifeoma Okwor","is_ca":true},{"name":"Jude E. Uzonna","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0728975426469038,"gpt":0.4127452399516908,"spread":0.339847697304787,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005543598,0.0008760638,0.005550913,0.0002749942,0.0001211673,0.00003732922,0.0007085272,0.0004134713,0.0001280021],"category_scores_gemma":[0.0001489102,0.0004540238,0.003772808,0.001016574,0.0002542066,0.00007676088,0.00003372747,0.0002987984,0.00001118354],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003907609,"about_ca_system_score_gemma":0.001291939,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005263047,"about_ca_topic_score_gemma":0.000003629209,"domain_scores_codex":[0.9959966,0.0004123615,0.001757453,0.0005791801,0.0007295634,0.0005248348],"domain_scores_gemma":[0.9954382,0.0004086493,0.001347332,0.002028593,0.0007052411,0.00007195484],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003013682,0.0007353181,0.000002147132,0.09571793,0.002900463,0.000008902345,0.0003224275,4.649189e-8,0.00006410884,0.0002982577,0.001418393,0.8982306],"study_design_scores_gemma":[0.001990024,0.003537769,0.00003470961,0.2443432,0.0007955295,0.0001417978,0.00002274999,2.204459e-7,0.0001004267,0.00009164769,0.7487054,0.0002364523],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00002181209,0.9886117,0.000005153436,0.0007212458,0.0001493087,0.009197622,0.0002282693,0.00003689459,0.001027991],"genre_scores_gemma":[0.000007494696,0.9937247,0.0002507545,0.0005214784,0.0002095219,0.001306803,0.0001192933,0.0001527515,0.003707201],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8979942,"threshold_uncertainty_score":0.9997911,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1982443638","doi":"10.2217/imt.14.108","title":"Lentiviral Vectors in Cancer Immunotherapy","year":2015,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network; Canada Research Chairs; University of Toronto","funders":"","keywords":"Immunotherapy; Viral vector; Cancer immunotherapy; Cancer; Insertional mutagenesis; Immune system; Genetic enhancement; Vector (molecular biology); Medicine; Computational biology; Gene delivery; Effector; Clinical trial; Biology; Immunology; Cancer research; Bioinformatics; Gene; Genome; Genetics","authors":[{"name":"Robyn A. A. Oldham","is_ca":true},{"name":"Elliot Berinstein","is_ca":true},{"name":"Jeffrey A. Medin","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03454148207282977,"gpt":0.3433136183843259,"spread":0.3087721363114962,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005229891,0.0002380659,0.0002194699,0.0001304046,0.00004185202,0.0000452613,0.0004396749,0.0001685458,0.00008384739],"category_scores_gemma":[0.00001806762,0.0002253501,0.0001181924,0.0002588246,0.0001183449,0.000010148,0.00004797213,0.0001864383,0.00003899561],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001077826,"about_ca_system_score_gemma":0.0003326994,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004746749,"about_ca_topic_score_gemma":0.0008578037,"domain_scores_codex":[0.9983702,0.0001914773,0.0002693621,0.0003957182,0.0002896921,0.0004834955],"domain_scores_gemma":[0.9991364,0.00001075977,0.00006870631,0.0005981961,0.0001006755,0.00008518809],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.005322959,0.0001817765,0.01021408,0.000003321854,0.000118958,0.00000578935,0.0003686644,0.0001922917,0.936711,0.00003088159,0.001378924,0.04547137],"study_design_scores_gemma":[0.008045159,0.004311217,0.007649384,0.00002873598,0.00000354988,0.00000907193,0.0001792921,0.0001148937,0.7592673,0.0003256907,0.2194367,0.0006290927],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9777226,0.02046283,0.0001061454,0.0003860453,0.0003566857,0.000317609,0.00001092057,0.00004555274,0.0005916338],"genre_scores_gemma":[0.9925969,0.004183993,0.0001183547,0.0009257263,0.0002825055,0.0001586508,0.00003371474,0.0001243455,0.001575779],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2180577,"threshold_uncertainty_score":0.9189512,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4376640915","doi":"10.2217/imt-2022-0139","title":"Association of Circadian Timing of Initial Infusions of Immune Checkpoint Inhibitors with Survival in Advanced Melanoma","year":2023,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Kingston Health Sciences Centre","funders":"","keywords":"Circadian rhythm; Medicine; Melanoma; Immune system; Immune checkpoint; Association (psychology); Oncology; Internal medicine; Immunotherapy; Immunology; Cancer research; Psychology","authors":[{"name":"Cynthia Yeung","is_ca":true},{"name":"Adi Kartolo","is_ca":true},{"name":"Justin Tong","is_ca":true},{"name":"Wilma M. Hopman","is_ca":true},{"name":"Tara Baetz","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01719611694627355,"gpt":0.3009920710369966,"spread":0.2837959540907231,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007534877,0.0001449097,0.0005516661,0.0003930732,0.00002758961,0.000003469935,0.0001051443,0.0001297654,0.0001318481],"category_scores_gemma":[0.00007309035,0.0001249755,0.0001880443,0.001008399,0.0001062537,0.00008368855,0.00001857896,0.0001515134,0.000002489006],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001508794,"about_ca_system_score_gemma":0.0002088874,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001182428,"about_ca_topic_score_gemma":0.0002384824,"domain_scores_codex":[0.9983116,0.00007236546,0.0008573108,0.0001570507,0.0003744781,0.000227162],"domain_scores_gemma":[0.9987602,0.000170405,0.0005928439,0.0002913367,0.0001582739,0.00002690992],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.004924738,0.0001876496,0.06987806,0.0001076565,0.0003673227,0.000006601228,0.002857707,0.00003433167,0.8967872,0.00002934319,0.00002301416,0.02479636],"study_design_scores_gemma":[0.009202248,0.001040458,0.6034461,0.0006757471,0.00003030036,0.000004006103,0.001031304,0.00007983029,0.3836025,0.00002582394,0.0007242855,0.0001374504],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997315,0.0007076844,0.00001468074,0.0004583708,0.0002283002,0.0003922643,0.0000249383,0.00003014426,0.0008286475],"genre_scores_gemma":[0.9984029,0.0009231979,0.0002512362,0.00003285469,0.00003473656,0.00002134501,0.00003667584,0.00003256162,0.0002644927],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.533568,"threshold_uncertainty_score":0.5096353,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2978287760","doi":"10.2217/imt-2018-0035","title":"Atezolizumab-Induced Sarcoid-Like Granulomatous Reaction in a Patient with Urothelial Cell Carcinoma","year":2018,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Sarcoidosis and Beryllium Toxicity Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa","funders":"","keywords":"Atezolizumab; Medicine; Sarcoidosis; Malignancy; Mediastinal lymph node; Lymph node; Lymph node biopsy; Biopsy; Mediastinal lymphadenopathy; Pathology; Carcinoma; Radiology; Immunotherapy; Cancer; Internal medicine; Nivolumab; Metastasis","authors":[{"name":"Michael A. Mitchell","is_ca":true},{"name":"Kevin T. Hogan","is_ca":true},{"name":"Kayvan Amjadi","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0186478648614335,"gpt":0.277726634204796,"spread":0.2590787693433625,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001915227,0.0002363272,0.000352457,0.0002818341,0.0001209449,0.00003914867,0.0001346428,0.0001398063,0.0001671084],"category_scores_gemma":[0.00001019865,0.000174365,0.00009880005,0.0004545731,0.000139222,0.000108306,0.00002458653,0.0003224259,0.0001828587],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002112228,"about_ca_system_score_gemma":0.0002146779,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002339463,"about_ca_topic_score_gemma":0.000275065,"domain_scores_codex":[0.9981515,0.00009634314,0.0003301546,0.0003881725,0.0005323294,0.0005014388],"domain_scores_gemma":[0.999042,0.00004223422,0.00009084302,0.0005406284,0.0001740684,0.0001102224],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.005729513,0.0007141907,0.01599395,0.00003066284,0.00003360077,0.0001926499,0.00189582,2.345737e-7,0.9382362,0.00001636626,0.0001579342,0.03699886],"study_design_scores_gemma":[0.01439689,0.009503887,0.1996758,0.0001637747,0.00002687721,0.000618884,0.0005354604,0.0002066126,0.7606822,0.00004151091,0.01369955,0.0004485246],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945424,0.0003492622,0.00002098696,0.0003935687,0.0001811904,0.0007822252,0.000005156086,0.00006573438,0.003659517],"genre_scores_gemma":[0.9980943,0.0001016107,0.0002333863,0.0007339163,0.0002196629,0.00008248234,0.0000104245,0.00006694685,0.0004573168],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1836818,"threshold_uncertainty_score":0.7110398,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1993673970","doi":"10.2217/imt.14.122","title":"Bidirectional Interactions of NK Cells and Dendritic Cells in Immunotherapy: Current and Future Perspective","year":2015,"lang":"en","type":"review","venue":"Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":25,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba; Apotex (Canada)","funders":"","keywords":"Crosstalk; Immunotherapy; Immune system; Tumor microenvironment; Cancer immunotherapy; Dendritic cell; Innate immune system; Biology; Acquired immune system; Cell biology; Immunology; Physics","authors":[{"name":"Sajid Mahmood","is_ca":true},{"name":"Deepak Upreti","is_ca":true},{"name":"Ibrahim Sow","is_ca":true},{"name":"Abdulaziz Alamri","is_ca":true},{"name":"Saravanan Nandagopal","is_ca":true},{"name":"Sam KP Kung","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02513291453161458,"gpt":0.3209390407875841,"spread":0.2958061262559695,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003416203,0.0005494204,0.00144877,0.0006863456,0.0001328022,0.00004274089,0.0001962876,0.0004646657,0.000697287],"category_scores_gemma":[0.00001118471,0.0004757709,0.0003253623,0.0003257594,0.0002764005,0.0002214535,0.00005919881,0.0011845,0.0001441912],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003537577,"about_ca_system_score_gemma":0.000245529,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002549576,"about_ca_topic_score_gemma":0.00002416126,"domain_scores_codex":[0.9976321,0.0005572459,0.0008594202,0.0005498735,0.00007381299,0.0003275254],"domain_scores_gemma":[0.9986005,0.0002482915,0.0005179656,0.0003757234,0.0002288822,0.00002859879],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002956616,0.000396246,0.00000675415,0.0009466071,0.0007051448,0.000002133638,0.001614037,2.606704e-7,0.0197736,0.0005062571,0.002526096,0.9732272],"study_design_scores_gemma":[0.001387494,0.0002068031,0.00002247685,0.00187478,0.0001049515,0.0002051497,0.0009653245,0.000001122008,0.001209177,0.00006017098,0.9935634,0.0003991734],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000373052,0.9867992,0.00002506227,0.00004401472,0.01134066,0.0006849981,0.00007096695,0.00004709562,0.0006149421],"genre_scores_gemma":[0.0001296345,0.9958876,0.00003602816,0.00003863464,0.0001880432,0.0001045346,0.0001152163,0.00007398907,0.003426329],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9910373,"threshold_uncertainty_score":0.9997694,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2070064055","doi":"10.2217/imt.09.80","title":"Immunization of Newborn and Adult Mice with Low Numbers of BCG Leads to Th1 Responses, Th1 Imprints and Enhanced Protection Upon BCG Challenge","year":2009,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University; University of Saskatchewan","funders":"Canadian Institutes of Health Research","keywords":"Vaccination; Medicine; Immunization; Immunology; Immune system; Context (archaeology); Tuberculosis; Immunity; Biology; Pathology","authors":[{"name":"Tadele G. Kiros","is_ca":true},{"name":"Carl A. Power","is_ca":false},{"name":"Guojian Wei","is_ca":true},{"name":"Peter A. Bretscher","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01353806602832203,"gpt":0.3039691230209426,"spread":0.2904310569926206,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000399521,0.000144957,0.0003875566,0.0001618908,0.00004963599,0.000006460713,0.00007132709,0.0001226016,0.00002021855],"category_scores_gemma":[0.0002308028,0.0001116829,0.00003554309,0.0002196402,0.00009589877,0.0000875862,0.0000148889,0.0001817435,0.000002926996],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004103636,"about_ca_system_score_gemma":0.00006234702,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006485982,"about_ca_topic_score_gemma":0.0001085502,"domain_scores_codex":[0.9988473,0.0001928121,0.0003093999,0.0002396759,0.0001744303,0.0002363648],"domain_scores_gemma":[0.9991508,0.00009048491,0.000131124,0.0003025213,0.0002420664,0.00008304087],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.009863529,0.0001437483,0.001779911,0.00006486446,0.00007619181,0.000001813702,0.001186506,0.000008429966,0.8402464,0.0001160038,0.00002095083,0.1464916],"study_design_scores_gemma":[0.006408925,0.009966977,0.527358,0.0005644843,0.00003080757,0.00007501126,0.0003743328,0.0003453501,0.4534008,0.0002062847,0.001029928,0.0002391007],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9910604,0.001271866,0.002175221,0.004341462,0.00001947055,0.0008134545,0.000004660114,0.00002494123,0.0002885644],"genre_scores_gemma":[0.9920017,0.005455931,0.001834424,0.0004688648,0.00002910519,0.00002964841,0.000008145044,0.0000192711,0.0001529393],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5255781,"threshold_uncertainty_score":0.4554299,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2162451701","doi":"10.2217/imt.14.7","title":"Alemtuzumab for the Treatment of Relapsing–Remitting Multiple Sclerosis","year":2014,"lang":"en","type":"review","venue":"Immunotherapy","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Alemtuzumab; Relapsing remitting; Multiple sclerosis; Medicine; Fingolimod; Oncology; Internal medicine; Immunology","authors":[{"name":"Carrie M. Hersh","is_ca":false},{"name":"Jeffrey Cohen","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2022904802481968,"gpt":0.4048349850202537,"spread":0.2025445047720569,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006104832,0.0005698335,0.002852321,0.0001852106,0.0003172451,0.00003577683,0.0003491071,0.0002654574,0.0000511058],"category_scores_gemma":[0.000485123,0.0002969566,0.001835264,0.0002692473,0.000277318,0.00002989073,0.00003663157,0.0002342736,0.00002587335],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004836104,"about_ca_system_score_gemma":0.0002564972,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001628864,"about_ca_topic_score_gemma":0.00001512597,"domain_scores_codex":[0.9973857,0.0001799426,0.001000417,0.0004816127,0.0004299868,0.0005223088],"domain_scores_gemma":[0.9931188,0.00475002,0.000611446,0.001215886,0.0002323151,0.00007149759],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001809581,0.0003067446,0.0000295662,0.005078903,0.002364182,4.348669e-7,0.0004046128,7.921209e-7,0.0001418029,0.00001432344,0.0005499696,0.9909277],"study_design_scores_gemma":[0.003823374,0.001310826,0.000173214,0.01416341,0.0008304513,0.000007098681,0.00004613727,0.000147319,0.00007632717,0.000002706918,0.9791914,0.0002277892],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00005149272,0.9935478,0.0005305022,0.0001529923,0.0003558077,0.005063661,0.0001108887,0.00006070821,0.0001261639],"genre_scores_gemma":[0.0001001873,0.9943106,0.001684541,0.00004629347,0.0005423565,0.001998822,0.00007864535,0.0001636196,0.001074958],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9906999,"threshold_uncertainty_score":0.9999483,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2007718183","doi":"10.2217/imt.13.81","title":"Ustekinumab for the Treatment of Crohn‘s Disease","year":2013,"lang":"en","type":"review","venue":"Immunotherapy","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"Genentech; ActoGeniX; Zalicus; Janssen Biotech; Wyeth","keywords":"Ustekinumab; Medicine; Crohn's disease; Psoriasis; Monoclonal antibody; Disease; Immunology; Immune system; Monoclonal; Crohn disease; Inflammatory bowel disease; Antibody; Tumor necrosis factor alpha; Internal medicine; Adalimumab","authors":[{"name":"Reena Khanna","is_ca":true},{"name":"Brian G. Feagan","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09589915221036092,"gpt":0.4150780252147817,"spread":0.3191788730044207,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001438744,0.0004028026,0.001604256,0.0001168326,0.00008152542,0.0000323072,0.0003316133,0.0001815013,0.0004859326],"category_scores_gemma":[0.00004408205,0.000189704,0.001352801,0.0001868776,0.000201551,0.00002705016,0.00001836085,0.0001150386,0.0001277641],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.008232607,"about_ca_system_score_gemma":0.00928878,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003372099,"about_ca_topic_score_gemma":0.000002205715,"domain_scores_codex":[0.9982812,0.00007323539,0.0005874399,0.0003305384,0.0003504146,0.0003771715],"domain_scores_gemma":[0.9969922,0.001065848,0.0002575542,0.00142743,0.0001373476,0.000119669],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003883885,0.0003478652,2.486668e-7,0.007483382,0.001379638,0.00003077485,0.0001035834,3.450962e-7,0.000001151884,0.0001125256,0.001139195,0.9890129],"study_design_scores_gemma":[0.009538817,0.0006377037,0.000008952185,0.003318058,0.001132448,0.00004482059,0.00001027518,0.0001986993,0.000005399232,0.0000220929,0.984927,0.0001557569],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004374121,0.9919026,0.00009656829,0.00008244895,0.0002390049,0.007382126,0.00009998921,0.00002868379,0.0001248265],"genre_scores_gemma":[0.000007575712,0.9835545,0.0001595932,0.00004764701,0.0003806751,0.003178626,0.0001009733,0.0001268814,0.01244354],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9888572,"threshold_uncertainty_score":0.9963276,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3047233339","doi":"10.2217/imt-2020-0158","title":"Romosozumab in the Treatment of Osteoporosis","year":2020,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Impact; McMaster University","funders":"Amgen","keywords":"Sclerostin; Osteoporosis; Medicine; Bone resorption; Bone mineral; Bone Density Conservation Agents; Wnt signaling pathway; Internal medicine; Bioinformatics; Chemistry; Signal transduction; Biology; Biochemistry","authors":[{"name":"Alexandra Kobza","is_ca":true},{"name":"Αλεξάνδρα Παπαϊωάννου","is_ca":true},{"name":"Arthur Lau","is_ca":true},{"name":"Jonathan D. Adachi","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0488655667525898,"gpt":0.3460848872339871,"spread":0.2972193204813973,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001196931,0.00008623531,0.0002464785,0.00003988073,0.00003059402,0.000007217426,0.00009352212,0.00004802418,0.0001768082],"category_scores_gemma":[0.000015829,0.00004929956,0.0000908821,0.0002815666,0.00005001406,0.00002301858,0.000003411363,0.00009044188,0.00003584157],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005230125,"about_ca_system_score_gemma":0.0001169287,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003717125,"about_ca_topic_score_gemma":0.00002423002,"domain_scores_codex":[0.9991254,0.00006980522,0.000242331,0.0001267247,0.0002399387,0.000195805],"domain_scores_gemma":[0.9995264,0.00008113132,0.00004130293,0.0002528593,0.00003327474,0.00006501161],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.006611992,0.003301033,0.07043677,0.0002489858,0.0001497195,0.0001179666,0.07621484,0.00000496752,0.1219866,0.0005209657,0.001530451,0.7188758],"study_design_scores_gemma":[0.02546831,0.02715914,0.4374343,0.0001051711,0.00003895079,0.00005682093,0.004312865,0.0004188456,0.04773647,0.0001319254,0.4568847,0.0002525195],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.972311,0.005388051,0.000005733922,0.02003613,0.00002822843,0.0006621868,0.000005707136,0.00001521138,0.001547795],"genre_scores_gemma":[0.9911674,0.004540047,0.0001874967,0.003844188,0.00006650534,0.00006065948,0.000009338882,0.00001373911,0.0001106886],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7186232,"threshold_uncertainty_score":0.2010377,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4408003542","doi":"10.1080/1750743x.2025.2464528","title":"ROCKET: a phase 3 program evaluating the efficacy and safety of rocatinlimab in moderate-to-severe atopic dermatitis","year":2025,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Innovaderm (Canada)","funders":"Amgen","keywords":"Atopic dermatitis; Medicine; Dermatology; Rocket (weapon); Engineering; Aeronautics","authors":[{"name":"Emma Guttman‐Yassky","is_ca":false},{"name":"Eric L. Simpson","is_ca":false},{"name":"Robert Bissonnette","is_ca":true},{"name":"Lawrence F. Eichenfield","is_ca":false},{"name":"Kenji Kabashima","is_ca":false},{"name":"Paula Carolina Luna","is_ca":false},{"name":"Jana Hercogová","is_ca":false},{"name":"Lynda Spelman","is_ca":false},{"name":"Margitta Worm","is_ca":false},{"name":"Ehsanollah Esfandiari","is_ca":false},{"name":"Takahiro Arai","is_ca":false},{"name":"Hirotaka Mano","is_ca":false},{"name":"Prista Charuworn","is_ca":false},{"name":"Andrea Wang","is_ca":false},{"name":"Greg Kricorian","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02051525263557304,"gpt":0.3718269398653076,"spread":0.3513116872297346,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001707222,0.0001111736,0.0002763688,0.00009112892,0.00009272169,0.00001507704,0.00009524053,0.00006069509,0.00003950532],"category_scores_gemma":[0.000122223,0.00007873982,0.00004462489,0.0002578035,0.00007979928,0.00004041947,0.00002564907,0.000123639,0.000004134464],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002273351,"about_ca_system_score_gemma":0.0001367812,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002819436,"about_ca_topic_score_gemma":0.000009845272,"domain_scores_codex":[0.999148,0.0001100527,0.0003165345,0.0001543737,0.0001110107,0.0001600123],"domain_scores_gemma":[0.9993649,0.0002135338,0.0000565378,0.0002745966,0.00006044729,0.00003003421],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.003207169,0.001174161,0.02863096,0.0001761043,0.0002055334,0.00002032172,0.002192983,0.00005186203,0.001919776,0.0002891019,0.0005544741,0.9615775],"study_design_scores_gemma":[0.04649408,0.001154286,0.9228901,0.001368285,0.0001381746,0.0001784665,0.0005324273,0.01153361,0.005579999,0.001455333,0.008397806,0.0002773958],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9883663,0.006284918,0.0002148606,0.002901966,0.00005027705,0.001171573,0.00000495867,0.00003662658,0.0009685319],"genre_scores_gemma":[0.9964385,0.0002522287,0.0006801691,0.002217176,0.00001033133,0.0001480947,0.000009054835,0.000009603576,0.0002348365],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9613001,"threshold_uncertainty_score":0.3210917,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2550798570","doi":"10.2217/imt-2016-0079","title":"Double-Blind, Placebo-Controlled, 1:1 Randomized Phase III Clinical Trial Of Immunoxel Honey Lozenges as an Adjunct Immunotherapy in 269 Patients with Pulmonary Tuberculosis","year":2016,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Bee Products Chemical Analysis","field":"Agricultural and Biological Sciences","cited_by":14,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Adjunct; Medicine; Placebo; Double blind; Lozenge; Clinical trial; Immunotherapy; Tuberculosis; Randomized controlled trial; Phases of clinical research; Pulmonary tuberculosis; Internal medicine; Pathology; Cancer","authors":[{"name":"Uyanga Batbold","is_ca":false},{"name":"Dmytro Butov","is_ca":false},{"name":"Galyna A Kutsyna","is_ca":false},{"name":"Narantsetseg Damdinpurev","is_ca":false},{"name":"Elena A. Grinishina","is_ca":false},{"name":"Otgonbayar Mijiddorj","is_ca":false},{"name":"Mikola E Kovolev","is_ca":false},{"name":"Khaliunaa Baasanjav","is_ca":false},{"name":"Tetiana Butova","is_ca":false},{"name":"Munkhburam Sandagdorj","is_ca":false},{"name":"Ochirbat Batbold","is_ca":false},{"name":"Ariungerel Tseveendorj","is_ca":false},{"name":"Erkhemtsetseg Chunt","is_ca":false},{"name":"Svetlana I Zaitzeva","is_ca":false},{"name":"Hanna Stepanenko","is_ca":false},{"name":"Natalia Makeeva","is_ca":false},{"name":"Igor V Mospan","is_ca":false},{"name":"Volodymyr S. Pylypchuk","is_ca":false},{"name":"John L Rowe","is_ca":false},{"name":"Peter S. Nyasulu","is_ca":false},{"name":"Vichai Jirathitikal","is_ca":true},{"name":"Allen I. Bain","is_ca":true},{"name":"Marina G Tarakanovskaya","is_ca":false},{"name":"Aldar S. Bourinbaiar","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02854180778147574,"gpt":0.3012245799919154,"spread":0.2726827722104397,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002775805,0.0005642371,0.002390576,0.0001018516,0.000144095,0.00007355817,0.0008839444,0.0003672677,0.001132328],"category_scores_gemma":[0.0001884144,0.0001743348,0.0009236797,0.0007390259,0.0006219955,0.0005200091,0.0000647355,0.0003307288,0.00003872916],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007299236,"about_ca_system_score_gemma":0.00005259982,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001305185,"about_ca_topic_score_gemma":0.0001532868,"domain_scores_codex":[0.9946367,0.001084099,0.002025646,0.0009395482,0.0007088406,0.0006051427],"domain_scores_gemma":[0.9963596,0.00175225,0.0008941099,0.0005004489,0.0003414919,0.0001520332],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6691479,0.003919181,0.0008714134,0.000002598545,0.000689688,0.000002754163,0.00007087398,6.852797e-7,0.1787024,0.00007016732,0.000008930851,0.1465134],"study_design_scores_gemma":[0.9796615,0.003196903,0.001186196,0.00008115491,0.0001295464,0.00000236628,0.00005784292,0.00002538955,0.01378426,0.0004974368,0.0008597568,0.0005177042],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9923567,0.001467788,0.00001742907,0.001808139,0.000279816,0.00369322,0.0000373824,0.0000751081,0.000264433],"genre_scores_gemma":[0.9952416,0.003005784,0.00009406769,0.000277285,0.0003279943,0.0005150501,0.0001112739,0.00001361139,0.0004132794],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3105136,"threshold_uncertainty_score":0.9997808,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2921861485","doi":"10.2217/imt-2018-0186","title":"Toxicity Patterns Associated with Chemotherapy/Immune Checkpoint Inhibitor Combinations: A Meta-Analysis","year":2019,"lang":"en","type":"review","venue":"Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Meta-analysis; Chemotherapy; Toxicity; Medicine; Immune checkpoint; Immune system; Immunotherapy; Oncology; Immunology; Internal medicine","authors":[{"name":"Omar Abdel‐Rahman","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0886360825971064,"gpt":0.3486131514574846,"spread":0.2599770688603782,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.001224286,0.001404346,0.009573022,0.001058163,0.0001939152,0.0001860654,0.0006184266,0.0008673623,0.003297375],"category_scores_gemma":[0.00004469523,0.0008994311,0.01087334,0.002745222,0.0002112067,0.0001750096,0.00005310263,0.0009871207,0.000105536],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008917893,"about_ca_system_score_gemma":0.0007579266,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002761249,"about_ca_topic_score_gemma":0.00008178262,"domain_scores_codex":[0.994528,0.0005128727,0.00205666,0.001147048,0.001013619,0.000741796],"domain_scores_gemma":[0.9950418,0.0004327689,0.001876099,0.002162433,0.0003539515,0.0001329881],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007373414,0.001542322,0.00003734289,0.002994703,0.7517525,0.000030906,0.0002421484,0.0000010359,0.00009555613,0.00002577428,0.0001365405,0.2424038],"study_design_scores_gemma":[0.005719923,0.001016378,0.000335993,0.002682888,0.3552176,0.00006120575,0.00003221985,0.0000119122,0.000133765,0.000006913186,0.6337318,0.001049389],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003300832,0.9939145,0.0003059026,0.0004766652,0.0002582156,0.003654605,0.0004531438,0.0002513571,0.0003554983],"genre_scores_gemma":[0.0006223688,0.987569,0.0001434372,0.001055551,0.0001111174,0.000819716,0.001507118,0.0003254231,0.00784627],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6335953,"threshold_uncertainty_score":0.9998707,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2043429701","doi":"10.2217/imt.13.141","title":"Employing an IL-23 p19 Vaccine to Block IL-23 Ameliorates Chronic Murine Colitis","year":2013,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"Canadian Institutes of Health Research","keywords":"Colitis; Medicine; Immunology; In vivo; Interleukin 23; Splenocyte; Pathogenesis; Inflammatory bowel disease; In vitro; Peptide vaccine; Interleukin; Antibody; Cytokine; Disease; Internal medicine; Epitope; Biology","authors":[{"name":"Qingdong Guan","is_ca":true},{"name":"Helen A Burtnick","is_ca":true},{"name":"Gefei Qing","is_ca":true},{"name":"Carolyn R. Weiss","is_ca":true},{"name":"G. Allan","is_ca":true},{"name":"Yanbing Ma","is_ca":false},{"name":"Richard Warrington","is_ca":true},{"name":"Zhikang Peng","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.006629204937353886,"gpt":0.248728499099141,"spread":0.2420992941617871,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001482037,0.0003123395,0.0002213972,0.00008109171,0.0001526749,0.0001139053,0.0004141948,0.0001602829,0.0003430794],"category_scores_gemma":[0.00002494374,0.0003071426,0.0001213587,0.0001297847,0.00004205671,0.00002073574,0.00009472874,0.0001085018,0.0007585521],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006838726,"about_ca_system_score_gemma":0.0001489785,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000164845,"about_ca_topic_score_gemma":0.0001832627,"domain_scores_codex":[0.9983736,0.0001048624,0.0003366063,0.000492666,0.0001611263,0.0005310979],"domain_scores_gemma":[0.9985881,0.000009329464,0.00009768652,0.0008912469,0.0001970088,0.0002165894],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.000371963,0.0001251591,0.003626251,0.00002527207,0.0001308287,0.00003107078,0.0001521171,0.0002047575,0.9835432,0.00005783382,0.004882021,0.006849568],"study_design_scores_gemma":[0.004391817,0.001723128,0.5265031,0.00007410156,0.00003044278,0.0000443571,0.0001537232,0.0003084211,0.2894038,0.0002218091,0.1759438,0.001201497],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972599,0.001026619,0.00009201438,0.0003318395,0.0002331326,0.0007251037,0.0000628843,0.00007838854,0.0001900924],"genre_scores_gemma":[0.9945684,0.0003934775,0.0004117978,0.001527252,0.0006613524,0.0002614074,0.0002101385,0.000107775,0.001858374],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6941394,"threshold_uncertainty_score":0.9999381,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4375855360","doi":"10.2217/imt-2023-0062","title":"Treatment of Plaque Psoriasis with Deucravacitinib (Poetyk Pso-2 Study): A Plain Language Summary","year":2023,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research","funders":"Bristol-Myers Squibb","keywords":"Psoriasis; Plaque psoriasis; Medicine; Dermatology","authors":[{"name":"Bruce Strober","is_ca":false},{"name":"Diamant Thaçi","is_ca":false},{"name":"Howard Sofen","is_ca":false},{"name":"Leon Kircik","is_ca":false},{"name":"Kenneth B. Gordon","is_ca":false},{"name":"Peter Foley","is_ca":false},{"name":"Phoebe Rich","is_ca":false},{"name":"C. Paul","is_ca":false},{"name":"Jerry Bagel","is_ca":false},{"name":"Elizabeth Colston","is_ca":false},{"name":"John Throup","is_ca":false},{"name":"Sudeep Kundu","is_ca":false},{"name":"Chitra Sekaran","is_ca":false},{"name":"Misti Linaberry","is_ca":false},{"name":"Subhashis Banerjee","is_ca":false},{"name":"Kim Papp","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01778521998774822,"gpt":0.2671503374702288,"spread":0.2493651174824805,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001579045,0.0003574495,0.0005639017,0.0002496786,0.0001781051,0.00001464729,0.0002259467,0.0001854263,0.0003521155],"category_scores_gemma":[0.000007127455,0.000250789,0.0001775625,0.0004573494,0.0001252795,0.00007034725,0.00002145294,0.00007826335,0.0005316535],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007470354,"about_ca_system_score_gemma":0.00007849951,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006552352,"about_ca_topic_score_gemma":0.0002115085,"domain_scores_codex":[0.9984559,0.0002812317,0.0003553836,0.0003934523,0.00007487094,0.0004391473],"domain_scores_gemma":[0.9989144,0.0002597771,0.0001603329,0.0005974857,0.00004496247,0.00002301295],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.009170914,0.004034135,0.05941157,0.00002859534,0.007129174,0.0004171329,0.0368442,0.0000148222,0.470347,0.0003521104,0.001386939,0.4108634],"study_design_scores_gemma":[0.07113162,0.02158901,0.1775834,0.0001507499,0.0008308386,0.0002455955,0.02580925,0.000008495618,0.6006485,0.0001001913,0.100452,0.001450321],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920935,0.005397552,0.00001210669,0.0001184946,0.000412332,0.0008313417,0.0002141153,0.0002634093,0.0006571356],"genre_scores_gemma":[0.9882407,0.001731591,0.0001248964,0.00003354687,0.0000601974,0.0003176058,0.0004025848,0.00006253612,0.009026404],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4094131,"threshold_uncertainty_score":0.9999945,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3199359059","doi":"10.2217/imt-2021-0133","title":"Immunoregulatory T cell Epitope Peptides for the Treatment of Allergic Disease","year":2021,"lang":"en","type":"review","venue":"Immunotherapy","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"Regeneron Pharmaceuticals","keywords":"Epitope; Immunology; Disease; Medicine; Immunotherapy; Epitope mapping; Antibody; Immune system; Pathology","authors":[{"name":"Rashi Ramchandani","is_ca":true},{"name":"Lubnaa Hossenbaccus","is_ca":true},{"name":"Anne K. Ellis","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04693637287601039,"gpt":0.3326651217605675,"spread":0.2857287488845571,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001117356,0.000397646,0.001609334,0.00007607191,0.0001230508,0.0000260098,0.0001371971,0.0001647344,0.0001470282],"category_scores_gemma":[0.00001312897,0.0002235288,0.001453222,0.000140135,0.0001052325,0.00002555048,0.00001010783,0.00008928386,0.00001136785],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001569389,"about_ca_system_score_gemma":0.0005721195,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002367465,"about_ca_topic_score_gemma":0.000001736307,"domain_scores_codex":[0.998513,0.0001022103,0.000645321,0.0003137953,0.0002123545,0.0002133443],"domain_scores_gemma":[0.9981214,0.0003913705,0.0003770499,0.0008781393,0.0001658394,0.00006617641],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001308232,0.0004815857,0.000002094159,0.002232224,0.001112559,0.00002662153,0.0003050175,0.000004468895,0.00002241269,0.0002613179,0.0004759,0.994945],"study_design_scores_gemma":[0.001472427,0.0004588394,0.0000465844,0.003438542,0.001081706,0.00002251326,0.000059005,0.00004613393,0.00002147014,0.00001478214,0.9931412,0.0001967781],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001465592,0.9967818,0.0001930565,0.0001006749,0.0003967027,0.002134879,0.000081363,0.00002578152,0.0001392218],"genre_scores_gemma":[0.00008915649,0.9936834,0.0002378119,0.00008990717,0.000348311,0.0003480091,0.0006207417,0.0001081189,0.004474519],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9947482,"threshold_uncertainty_score":0.9115239,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2908942081","doi":"10.2217/imt-2018-0167","title":"Immune Checkpoint Inhibitors and Non-Small-Cell Lung Cancer Management: 2018 Update","year":2019,"lang":"en","type":"editorial","venue":"Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Pembrolizumab; Atezolizumab; Nivolumab; Medicine; Lung cancer; Oncology; Internal medicine; Docetaxel; Avelumab; Ipilimumab; Cancer; Immunotherapy","authors":[{"name":"Omar Abdel‐Rahman","is_ca":true},{"name":"Don Morris","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.005902408804642505,"gpt":0.2602707838035951,"spread":0.2543683749989526,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006821001,0.0009723294,0.001360811,0.0004201459,0.0001947599,0.0001861836,0.0004898316,0.001199065,0.0007070253],"category_scores_gemma":[0.00001222768,0.0008536276,0.0006422207,0.0003760897,0.0002302439,0.0001532724,0.000169874,0.001208272,0.0001162747],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006837299,"about_ca_system_score_gemma":0.0005788921,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001571978,"about_ca_topic_score_gemma":0.00003646023,"domain_scores_codex":[0.9960055,0.00007477547,0.001157719,0.001080222,0.0008698046,0.0008119533],"domain_scores_gemma":[0.9974046,0.0001443678,0.000711165,0.001395219,0.000207609,0.0001370472],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.005720158,0.0002536766,0.0002691631,0.002330377,0.003031428,0.0000642323,0.000523633,0.000001322693,0.03329525,0.000004446834,0.929149,0.02535728],"study_design_scores_gemma":[0.01499165,0.0004232154,0.0009466347,0.002189493,0.0005421899,0.000009025604,0.0001006383,0.000044962,0.006820779,0.000009516677,0.9729915,0.0009304444],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.02273719,0.1644692,0.00008492187,0.0007851321,0.804007,0.003212612,0.000293508,0.0001949664,0.004215504],"genre_scores_gemma":[0.002502617,0.4100301,0.0007919825,0.001244901,0.5193053,0.0006859327,0.001054227,0.0006822309,0.0637027],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.2847017,"threshold_uncertainty_score":0.9993914,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3109227879","doi":"10.2217/imt-2020-0265","title":"Prognosticating Role of Serum Eosinophils on Immunotherapy Efficacy in Patients with Advanced Melanoma","year":2020,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University","funders":"","keywords":"Eosinophilia; Medicine; Eosinophil; Melanoma; Immunotherapy; Internal medicine; Immunology; Retrospective cohort study; Gastroenterology; Oncology; Cancer research; Cancer; Asthma","authors":[{"name":"Adi Kartolo","is_ca":true},{"name":"Ryan Holstead","is_ca":true},{"name":"Wilma M. Hopman","is_ca":true},{"name":"Tara Baetz","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.006064718479399405,"gpt":0.2116574494295564,"spread":0.205592730950157,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008587703,0.0002413599,0.0003581205,0.0001145013,0.00008612004,0.00001350577,0.0002276749,0.0001442519,0.0007208198],"category_scores_gemma":[0.00004429286,0.0001961233,0.00008762709,0.0002527443,0.00009375824,0.0001509166,0.00001791253,0.0003520336,0.0002237429],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004526048,"about_ca_system_score_gemma":0.00003441874,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002073797,"about_ca_topic_score_gemma":0.000001433155,"domain_scores_codex":[0.998728,0.0001427966,0.0004491586,0.0003156194,0.00007028245,0.0002940799],"domain_scores_gemma":[0.9991763,0.0001360515,0.0002641638,0.0003083422,0.0000988851,0.00001622567],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.01066602,0.001270638,0.07274279,0.00001343492,0.0002863667,8.324822e-7,0.002462036,0.00009750787,0.7287014,0.0003967827,0.00009327097,0.183269],"study_design_scores_gemma":[0.01482846,0.005289258,0.668733,0.0001441354,0.000008717061,0.000002293834,0.0003354811,0.00001768053,0.285443,0.00001658089,0.02484589,0.0003355468],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957527,0.001730241,0.00003355549,0.0003201503,0.0004046252,0.0006276846,0.000009988614,0.00007698296,0.00104405],"genre_scores_gemma":[0.9985976,0.0001079792,0.000100788,0.0008542764,0.00001545326,0.00003047224,0.00006472351,0.0000452926,0.0001834226],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5959902,"threshold_uncertainty_score":0.7997676,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4386591643","doi":"10.2217/imt-2023-0039","title":"Association Between Age and Efficacy of First-Line Immunotherapy-Based Combination Therapies for Mrcc: A Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"Immunotherapy","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Meta-analysis; Renal cell carcinoma; Sunitinib; Hazard ratio; Internal medicine; Kidney cancer; Immunotherapy; Oncology; Cancer; Confidence interval","authors":[{"name":"Takafumi Yanagisawa","is_ca":false},{"name":"Fahad Quhal","is_ca":false},{"name":"Tatsushi Kawada","is_ca":false},{"name":"Kensuke Bekku","is_ca":false},{"name":"Ekaterina Laukhtina","is_ca":false},{"name":"Paweł Rajwa","is_ca":false},{"name":"Markus von Deimling","is_ca":false},{"name":"Marcin Chłosta","is_ca":false},{"name":"Benjamin Pradère","is_ca":false},{"name":"Pierre I. Karakiewicz","is_ca":true},{"name":"Keiichiro Mori","is_ca":false},{"name":"Takahiro Kimura","is_ca":false},{"name":"Manuela Schmidinger","is_ca":false},{"name":"Shahrokh F. Shariat","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1570885263418611,"gpt":0.3821562660851957,"spread":0.2250677397433346,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001230736,0.0007339109,0.006565322,0.0009883291,0.000135768,0.00006731755,0.00023728,0.0005242018,0.0001139143],"category_scores_gemma":[0.0001046015,0.0005138011,0.005555232,0.001226581,0.00008093517,0.0000563784,0.00002158215,0.0002834979,0.00001244721],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005152338,"about_ca_system_score_gemma":0.0001707896,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001627429,"about_ca_topic_score_gemma":0.0000305383,"domain_scores_codex":[0.9965617,0.0003521716,0.001458249,0.0006215803,0.000633918,0.0003723808],"domain_scores_gemma":[0.9939357,0.003132238,0.001661829,0.0009023856,0.0002985265,0.00006934432],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.0002808473,0.0005054736,0.0003323116,0.006238671,0.6749052,0.00001316984,0.0003493338,0.000007066045,0.00002576591,0.00004238754,0.00007381408,0.3172259],"study_design_scores_gemma":[0.006880107,0.001515361,0.002741241,0.0008216238,0.5487387,0.000002363251,0.00001215132,0.00003796535,0.00008740632,0.0001467673,0.4384906,0.0005257306],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001122271,0.9927563,0.0008545556,0.0004474645,0.00007266714,0.004168386,0.0004315874,0.0001201758,0.00002657034],"genre_scores_gemma":[0.001454917,0.9917971,0.0008449937,0.00007406967,0.0001022164,0.001120196,0.00218433,0.000216413,0.002205749],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.4384168,"threshold_uncertainty_score":0.9997314,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4282831736","doi":"10.2217/imt-2021-0250","title":"No Association Between BMI and Immunotoxicity or Clinical Outcomes for Immune Checkpoint Inhibitors","year":2022,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Kingston Health Sciences Centre","funders":"","keywords":"Medicine; Internal medicine; Adverse effect; Oncology; Immune system; Immune checkpoint; Immunotherapy; Retrospective cohort study; Cancer; Population; Immunology","authors":[{"name":"Cynthia Yeung","is_ca":true},{"name":"Adi Kartolo","is_ca":true},{"name":"Ryan Holstead","is_ca":true},{"name":"Gordon Taylor Moffat","is_ca":true},{"name":"Lilian Hanna","is_ca":true},{"name":"Wilma M. Hopman","is_ca":true},{"name":"Tara Baetz","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03765313257344467,"gpt":0.3521172211629623,"spread":0.3144640885895177,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002803065,0.0002992926,0.0008560474,0.0001357251,0.0005120058,0.00005712933,0.0002071127,0.0001953765,0.0006946473],"category_scores_gemma":[0.0003127747,0.0002383083,0.0007026693,0.0002629904,0.0001113664,0.0001179901,0.000098454,0.000509004,0.00001506453],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006213278,"about_ca_system_score_gemma":0.0002550343,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003256805,"about_ca_topic_score_gemma":0.000009765259,"domain_scores_codex":[0.9971675,0.0002202518,0.001234364,0.0004434993,0.0004875391,0.0004468135],"domain_scores_gemma":[0.9978349,0.0008638899,0.0005763704,0.0004912745,0.0001517614,0.0000818253],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02482721,0.0009136664,0.7610055,0.0000993918,0.004612154,0.00001085436,0.0006951974,0.000001043547,0.09096732,0.00005058691,0.004102473,0.1127146],"study_design_scores_gemma":[0.01703297,0.002872381,0.6098418,0.00003958467,0.0001447084,0.00001940154,0.000199675,0.00003391568,0.003813365,0.00007625421,0.3655686,0.0003573086],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.990419,0.002380161,0.0001455655,0.00308599,0.001563561,0.001771384,0.0001598717,0.0001521791,0.0003222908],"genre_scores_gemma":[0.966998,0.002502907,0.001676969,0.003908927,0.0008673767,0.0007689402,0.0002070336,0.0001510821,0.02291881],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3614661,"threshold_uncertainty_score":0.9717929,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4384662972","doi":"10.2217/imt-2023-0012","title":"Mirikizumab for the Treatment of Moderate to Severe Ulcerative Colitis","year":2023,"lang":"en","type":"review","venue":"Immunotherapy","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University; University of Calgary","funders":"","keywords":"Ulcerative colitis; Tofacitinib; Medicine; Colitis; Drug; Inflammation; Internal medicine; Immunology; Pharmacology; Disease","authors":[{"name":"Jurij Hanžel","is_ca":false},{"name":"Christopher Ma","is_ca":true},{"name":"Vipul Jairath","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04020959227294852,"gpt":0.3431351967940178,"spread":0.3029256045210693,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001033372,0.0003443929,0.0006279857,0.00004632179,0.0001096407,0.00002941293,0.0002820677,0.000200533,0.00001756505],"category_scores_gemma":[0.00001619416,0.0002212866,0.0006550954,0.00008250658,0.00005290238,0.000001444284,0.00002314815,0.00003907846,0.00003770217],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007745982,"about_ca_system_score_gemma":0.0003604437,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001680101,"about_ca_topic_score_gemma":0.00007004617,"domain_scores_codex":[0.9988416,0.0001154872,0.0003738166,0.0003388299,0.00009179873,0.0002384988],"domain_scores_gemma":[0.998917,0.00008137722,0.0001824536,0.0006651232,0.0001073172,0.00004672677],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002191314,0.000108267,2.978383e-7,0.001321297,0.001929011,0.0000110215,0.0002637217,0.00005179624,0.00004330588,0.0001916855,0.001744004,0.9921443],"study_design_scores_gemma":[0.0007929775,0.0005025813,0.00005622431,0.0004745334,0.000186508,0.000005514928,0.00001881517,0.00001195142,0.0001296478,0.00002926669,0.997546,0.000246008],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0006316854,0.9942319,0.0002640866,0.00003003845,0.0002543445,0.003369186,0.001133907,0.00001708522,0.00006770326],"genre_scores_gemma":[0.00002229886,0.9919767,0.0001290363,0.00008861451,0.0002542643,0.002414058,0.0003401781,0.000111321,0.004663562],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.995802,"threshold_uncertainty_score":0.9023804,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4394873105","doi":"10.2217/imt-2023-0219","title":"Positioning risankizumab in the treatment algorithm of moderate-to-severe Crohn's disease","year":2024,"lang":"en","type":"review","venue":"Immunotherapy","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Crohn's disease; Internal medicine; Monoclonal antibody; Monoclonal; Disease; Immunology; Antibody","authors":[{"name":"Francesca Lusetti","is_ca":false},{"name":"Ferdinando D’Amico","is_ca":false},{"name":"Mariangela Allocca","is_ca":false},{"name":"Federica Furfaro","is_ca":false},{"name":"Alessandra Zilli","is_ca":false},{"name":"Gionata Fiorino","is_ca":false},{"name":"Tommaso Lorenzo Parigi","is_ca":false},{"name":"Simona Radice","is_ca":false},{"name":"Laurent Peyrin‐Biroulet","is_ca":true},{"name":"Silvio Danese","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01637599975543938,"gpt":0.3122671550094165,"spread":0.2958911552539771,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001453565,0.0004153971,0.0005311236,0.0001190825,0.00006187488,0.00007047749,0.0003841919,0.0001797624,0.00002287723],"category_scores_gemma":[0.000007314935,0.0002671594,0.0005767943,0.0001577626,0.00005070182,0.000003321127,0.00003742471,0.0001326388,0.00005469015],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001029893,"about_ca_system_score_gemma":0.0004252491,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002219979,"about_ca_topic_score_gemma":0.000008247368,"domain_scores_codex":[0.9984745,0.0002442997,0.0004411016,0.0004322627,0.0001637055,0.0002441715],"domain_scores_gemma":[0.998996,0.00001807561,0.0001224826,0.0007615366,0.0000349172,0.00006697267],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003564232,0.0002578149,0.000002787589,0.00136216,0.0004842883,0.0006719205,0.0002609547,0.0000424712,0.00002733085,0.00009885144,0.0004287526,0.9960063],"study_design_scores_gemma":[0.0006610666,0.0001996673,0.0002515085,0.002343171,0.0004349147,0.00002426748,0.00002307151,0.00005028647,0.00001460803,0.00009316672,0.9954808,0.0004234264],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001880603,0.9959897,0.0001255584,0.00002187607,0.0001688715,0.001195166,0.0004401835,0.00001275296,0.0001652781],"genre_scores_gemma":[0.0003355423,0.9973875,0.000224003,0.0001593336,0.000208643,0.0006056944,0.0005237635,0.00008499978,0.000470534],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9955828,"threshold_uncertainty_score":0.9999781,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1979255880","doi":"10.2217/imt.10.44","title":"Emerging applications of lentiviral vectors in dendritic cell-based immunotherapy","year":2010,"lang":"en","type":"review","venue":"Immunotherapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"Canadian Institutes of Health Research","keywords":"Immunotherapy; Dendritic cell; Immunology; Viral vector; Immune system; Cancer immunotherapy; Antigen; Biology; Antigen-presenting cell; T cell; Autoimmunity; Cytotoxic T cell; Medicine; In vitro; Recombinant DNA","authors":[{"name":"Huiming Wang","is_ca":true},{"name":"Liang Zhang","is_ca":true},{"name":"Sam K. P. Kung","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01832265053708337,"gpt":0.3438783695124331,"spread":0.3255557189753497,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006083378,0.0005991244,0.001185181,0.0005140165,0.00009680943,0.00004142884,0.001098707,0.0007300529,0.0001431214],"category_scores_gemma":[0.00001361288,0.0005736932,0.0007881031,0.0006081885,0.0002410317,0.000006187291,0.0000629358,0.0007439618,0.00003934997],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007431122,"about_ca_system_score_gemma":0.0008125421,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005471327,"about_ca_topic_score_gemma":0.0001347059,"domain_scores_codex":[0.9970425,0.0003920382,0.000934953,0.0007052849,0.0003418339,0.0005833328],"domain_scores_gemma":[0.9977569,0.0000831467,0.0004455109,0.001534268,0.0001153791,0.00006478196],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003406462,0.0003409577,0.00002521755,0.001174143,0.0001570742,0.000002464397,0.00003306069,0.00001168531,0.1208547,0.00001298546,0.00003618206,0.8770109],"study_design_scores_gemma":[0.001334734,0.0008321439,0.000006236049,0.0006657135,0.00003590399,0.000005063315,0.00001114279,0.000007729664,0.0346697,0.00002167772,0.9618714,0.0005385671],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003691805,0.9933361,0.0007620024,0.00001664816,0.0001887276,0.001632861,0.00008513145,0.00002327039,0.0002634059],"genre_scores_gemma":[0.002129546,0.9950554,0.0003350459,0.00008220175,0.0002059334,0.001035726,0.0004452459,0.0002334777,0.0004774455],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9618352,"threshold_uncertainty_score":0.9996715,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4383186917","doi":"10.2217/imt-2023-0069","title":"A Plain Language Summary on Ritlecitinib Treatment for Adults and Adolescents with Alopecia Areata","year":2023,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"Pfizer","keywords":"Alopecia areata; Medicine; Dermatology; Pediatrics","authors":[{"name":"Brett King","is_ca":false},{"name":"Xingqi Zhang","is_ca":false},{"name":"Walter Gubelin Harcha","is_ca":false},{"name":"Jacek C. Szepietowski","is_ca":false},{"name":"Jerry Shapiro","is_ca":false},{"name":"Charles Lynde","is_ca":true},{"name":"Natasha Atanaskova Mesinkovska","is_ca":false},{"name":"Samuel H. Zwillich","is_ca":false},{"name":"Lynne Napatalung","is_ca":false},{"name":"Dalia Wajsbrot","is_ca":false},{"name":"Rana Fayyad","is_ca":false},{"name":"Amy Freyman","is_ca":false},{"name":"Debanjali Mitra","is_ca":false},{"name":"Vivek S. Purohit","is_ca":false},{"name":"Rodney Sinclair","is_ca":false},{"name":"Robert Wołk","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01251077123518095,"gpt":0.2805351663317076,"spread":0.2680243950965266,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004893376,0.0001427315,0.0001890208,0.00009316477,0.00006184077,0.00001373463,0.00003902964,0.00004802895,0.00001936774],"category_scores_gemma":[0.0000121981,0.00009679556,0.00004903585,0.0001258999,0.00003498454,0.00002565133,0.000004830694,0.00004493738,0.00003659126],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003401261,"about_ca_system_score_gemma":0.00004060486,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001091288,"about_ca_topic_score_gemma":0.0001113977,"domain_scores_codex":[0.9993464,0.00001311738,0.00009980284,0.0002074925,0.0001091265,0.0002239988],"domain_scores_gemma":[0.9996374,0.00003855311,0.00002266957,0.0002134869,0.00001945049,0.00006840134],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.04758425,0.001329977,0.06587759,0.0004045485,0.0004892521,0.0003562075,0.01528608,0.000004792561,0.006460037,0.0002649915,0.007693863,0.8542484],"study_design_scores_gemma":[0.1744328,0.02489839,0.484338,0.005689836,0.0001871277,0.0001114292,0.01334828,0.001074831,0.01107713,0.0001710646,0.2834293,0.001241786],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960495,0.001043968,0.00004446887,0.0005792598,0.0000432656,0.0008623943,0.00007021109,0.0001234311,0.001183467],"genre_scores_gemma":[0.9956713,0.0008208894,0.0001389817,0.001017166,0.00008636085,0.0001444804,0.0001863568,0.00004280619,0.00189161],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8530066,"threshold_uncertainty_score":0.3947208,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3210787730","doi":"10.2217/imt-2021-0068","title":"Association Between PD-L1 Inhibitor, Tumor Site and Adverse Events of Potential Immune Etiology Within the US FDA Adverse Event Reporting System","year":2021,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Adverse effect; Adverse Event Reporting System; Common Terminology Criteria for Adverse Events; Internal medicine; Ipilimumab; Oncology; Cancer; Immunotherapy; Nivolumab; Etiology; MedDRA; Kidney cancer; Pharmacovigilance","authors":[{"name":"Omar Abdel‐Rahman","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01024507710060336,"gpt":0.2668065637972968,"spread":0.2565614866966934,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002199407,0.0002413856,0.0006670259,0.00008674728,0.000226735,0.00001010097,0.000109186,0.000185176,0.000085408],"category_scores_gemma":[0.0002417615,0.0001829714,0.0003753924,0.0002965616,0.00009956431,0.0001013717,0.00005616687,0.0003599468,0.00001117087],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004089519,"about_ca_system_score_gemma":0.0002853732,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000647896,"about_ca_topic_score_gemma":0.00003484037,"domain_scores_codex":[0.9967927,0.000391836,0.001701694,0.0003563121,0.0004489883,0.0003084485],"domain_scores_gemma":[0.996523,0.0001489189,0.002462716,0.0005276486,0.0002839127,0.00005380496],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.003048438,0.0001651613,0.3112807,0.0002318358,0.002429385,0.0001508143,0.001660603,0.00005573065,0.676317,0.00003627819,0.00009578478,0.004528283],"study_design_scores_gemma":[0.007785731,0.0004451776,0.9173564,0.0007464971,0.0003938092,0.0004658354,0.001918288,0.0001837832,0.06729725,0.00002536636,0.003102027,0.0002797793],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944671,0.00286713,0.0001502901,0.0008315501,0.0009304679,0.0005401009,0.0000280529,0.00005869372,0.000126606],"genre_scores_gemma":[0.997578,0.0003627406,0.0002584687,0.0003407623,0.0002847028,0.00003160108,0.00007699194,0.00004119635,0.00102554],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6090198,"threshold_uncertainty_score":0.7461358,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2111454565","doi":"10.2217/imt.10.40","title":"T-Cell-Directed Treatment Strategies for Type 1 Diabetes and the Confounding Role of Inflammation","year":2010,"lang":"en","type":"editorial","venue":"Immunotherapy","topic":"Diabetes and associated disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases; National Institutes of Health","keywords":"Type 2 diabetes; Inflammation; Confounding; Medicine; Diabetes mellitus; Type 1 diabetes; Bioinformatics; Immunology; Internal medicine; Biology; Endocrinology","authors":[{"name":"Maria Koulmanda","is_ca":false},{"name":"Terry B. Strom","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.00426918085693779,"gpt":0.2497773023748755,"spread":0.2455081215179377,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001551667,0.0001847859,0.0002620461,0.00002413918,0.0000788765,0.00007266863,0.0001254995,0.0004740012,0.000006344038],"category_scores_gemma":[0.00008902622,0.0001255072,0.0001110193,0.00003449877,0.0001264942,0.000003787072,0.0000144141,0.00009994047,9.09144e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001090881,"about_ca_system_score_gemma":0.0001849435,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006090682,"about_ca_topic_score_gemma":0.00003581671,"domain_scores_codex":[0.9993301,0.00004435076,0.0001915224,0.0001778923,0.0000963146,0.0001597992],"domain_scores_gemma":[0.9991826,0.0001769859,0.0002422841,0.0002074716,0.0001768729,0.00001373163],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004532686,0.00005023548,0.00005848091,0.00003660514,0.0005536896,2.640385e-8,0.0003633592,0.000006339035,0.9254152,0.0002054153,0.05777138,0.01508605],"study_design_scores_gemma":[0.003544864,0.0004649251,0.00000503534,0.00001906844,0.00005667224,2.235927e-8,0.0002454272,0.0000751545,0.07379601,0.0005585503,0.9210821,0.0001521927],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"editorial","genre_scores_codex":[0.7978868,0.0303404,0.00001403254,0.0000708025,0.1693152,0.001140531,0.0002698715,0.00003390205,0.0009284291],"genre_scores_gemma":[0.4532469,0.05381653,0.0005753258,0.0001044226,0.474346,0.0009425895,0.01241411,0.0003408246,0.0042133],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.8633107,"threshold_uncertainty_score":0.5118036,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2097078544","doi":"10.2217/imt.12.17","title":"Distinct Roles of Dendritic and B Cells in the Activation of Naive CD4 <sup>+</sup> T Cells","year":2012,"lang":"en","type":"editorial","venue":"Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Saskatchewan","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Cell biology; Chemistry; Molecular biology; Biology; Immunology","authors":[{"name":"Christopher D. Rudulier","is_ca":true},{"name":"David R. Kroeger","is_ca":true},{"name":"Peter A. Bretscher","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.007320964166931451,"gpt":0.2407633208539423,"spread":0.2334423566870109,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00105246,0.000533893,0.001018891,0.000328928,0.0001499922,0.00002861007,0.0007888064,0.001286584,0.0002404307],"category_scores_gemma":[0.0001464917,0.0003968687,0.0002693102,0.0002521833,0.0007581677,0.0001884973,0.00005558828,0.001105881,0.00003788695],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006756924,"about_ca_system_score_gemma":0.0002289141,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006561845,"about_ca_topic_score_gemma":0.00001682935,"domain_scores_codex":[0.9966826,0.001231632,0.0009743401,0.0003780329,0.0001948662,0.0005385251],"domain_scores_gemma":[0.9947833,0.003492485,0.0007264136,0.0007965757,0.0001891928,0.00001199738],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003392049,0.0005737353,0.00008625856,0.0002026654,0.0006677053,0.000001857327,0.01103808,0.000007650876,0.8815967,0.0001110269,0.0907703,0.01155194],"study_design_scores_gemma":[0.002794567,0.000496477,0.0007073785,0.0003987289,0.00006955364,0.000005350391,0.001087266,0.000001790975,0.3565399,0.00005850539,0.6374894,0.0003511205],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6840325,0.1058797,0.00009245153,0.0001077207,0.2070545,0.001469529,0.001048362,0.00005214964,0.0002630802],"genre_scores_gemma":[0.946014,0.01937087,0.00008926778,0.000134651,0.03043252,0.0001736148,0.0009192367,0.0002004616,0.002665382],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5467191,"threshold_uncertainty_score":0.9998483,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3041847701","doi":"10.2217/imt-2020-0153","title":"How COVID-19 Affects Patients Receivingc anticytokine and JAK Inhibitors in Rheumatology and Dermatology","year":2020,"lang":"en","type":"letter","venue":"Immunotherapy","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St Joseph's Health Care; Western University","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Rheumatology; Medicine; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Dermatology; Internal medicine; Immunology; Virology","authors":[{"name":"Ting Yi Jessica Chang","is_ca":true},{"name":"Janet Pope","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01718533552473916,"gpt":0.280928578010123,"spread":0.2637432424853838,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001522467,0.0004719292,0.001347195,0.0005254328,0.0001324638,0.00009049916,0.0001846725,0.0009417241,0.00005437694],"category_scores_gemma":[0.0005529682,0.0004235854,0.00009937747,0.0002809383,0.0005371428,0.0001372878,0.0001339459,0.001905381,0.00001396476],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001188568,"about_ca_system_score_gemma":0.000382249,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001562637,"about_ca_topic_score_gemma":0.00001342497,"domain_scores_codex":[0.9975219,0.0003717399,0.0004797706,0.0006548605,0.0003501579,0.000621593],"domain_scores_gemma":[0.9987232,0.0003836064,0.0002509056,0.0004274788,0.00006530145,0.0001494868],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006362862,0.0001110817,0.2643878,0.00326174,0.0003063632,0.002364232,0.001690985,9.938385e-8,0.001283016,0.00003091673,0.7121548,0.01377272],"study_design_scores_gemma":[0.007937842,0.0004645275,0.01222015,0.0003433164,0.0000254547,0.0005860181,0.0001068447,0.00003907045,0.0001853699,0.0001160337,0.97756,0.0004152952],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.2633296,0.01060899,0.00002551277,0.72448,0.0002180776,0.001115765,0.00001564445,0.00008522697,0.0001211339],"genre_scores_gemma":[0.3024033,0.0257608,0.0001443807,0.6691089,0.000243089,0.0002093886,0.000587078,0.0002762277,0.001266891],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.2654053,"threshold_uncertainty_score":0.9998216,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2792760898","doi":"10.2217/imt-2017-0162","title":"CD19-specific Chimeric Antigen Receptor-Modified (CAR)-T cell Therapy for the Treatment of Chronic Lymphocytic Leukemia in the Ibrutinib Era","year":2018,"lang":"en","type":"editorial","venue":"Immunotherapy","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Chronic lymphocytic leukemia; Ibrutinib; Medicine; Chimeric antigen receptor; Leukemia; Oncology; Cancer; Immunology; Internal medicine; Immunotherapy","authors":[{"name":"Kevin A. Hay","is_ca":true},{"name":"Cameron J. Turtle","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02654790113269132,"gpt":0.3216215715794757,"spread":0.2950736704467843,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001541239,0.001080917,0.001732046,0.0003784774,0.0003775246,0.0001214919,0.001786327,0.001217635,0.0005209462],"category_scores_gemma":[0.0001063067,0.0005866179,0.00105213,0.0008790525,0.0008367351,0.00008977942,0.0000517738,0.0008250774,0.0001308223],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.07932212,"about_ca_system_score_gemma":0.06380812,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004460128,"about_ca_topic_score_gemma":0.0001141041,"domain_scores_codex":[0.9937703,0.0004554855,0.001365906,0.001155991,0.001916406,0.001335929],"domain_scores_gemma":[0.9899448,0.005415531,0.0007207012,0.003294325,0.0005112545,0.0001134283],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01317038,0.0008164279,0.000008058807,0.0003343277,0.001449617,0.00003071191,0.006694825,0.0001609457,0.009689714,0.00003738696,0.9114397,0.05616789],"study_design_scores_gemma":[0.07028996,0.007856034,0.00004961228,0.0002963952,0.00009486583,0.00001547377,0.0003855546,0.00261695,0.008015098,0.0000442103,0.9098305,0.0005054112],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.1555645,0.2886347,0.0003252146,0.0005504345,0.532791,0.01929051,0.0006705196,0.0002295936,0.00194352],"genre_scores_gemma":[0.03178715,0.4694623,0.0002511836,0.0002324332,0.4902411,0.002489714,0.00100575,0.0004725291,0.004057837],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.1808275,"threshold_uncertainty_score":0.9996585,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4409810942","doi":"10.1080/1750743x.2025.2491295","title":"Rozanolixizumab for Myasthenia Gravis: a breakthrough treatment and future prospects","year":2025,"lang":"en","type":"review","venue":"Immunotherapy","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Myasthenia gravis; Medicine; Intensive care medicine; Immunology","authors":[{"name":"Alexandria Matic","is_ca":true},{"name":"Vera Bril","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02313870609892407,"gpt":0.3524213016010471,"spread":0.329282595502123,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001168319,0.0008375637,0.002880832,0.0002512531,0.0001721968,0.00008534348,0.000177448,0.0005066598,0.00007296911],"category_scores_gemma":[0.000009089426,0.0005400686,0.001027803,0.0003039686,0.0000822963,0.00004610018,0.00002866766,0.0002426808,0.00001992237],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002797088,"about_ca_system_score_gemma":0.0006491097,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003938395,"about_ca_topic_score_gemma":0.000006645416,"domain_scores_codex":[0.9979067,0.00006788222,0.0006598482,0.0007273469,0.0001657663,0.0004724065],"domain_scores_gemma":[0.9985042,0.0001399575,0.0002840226,0.0008709367,0.0000916022,0.0001092408],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002853471,0.0001739559,0.000004263172,0.01008566,0.001131858,0.00002215139,0.0002856531,3.085426e-9,0.000004038199,0.004957768,0.0003944591,0.9826549],"study_design_scores_gemma":[0.004366511,0.001474808,0.00002061536,0.01001342,0.001277651,0.000428589,0.00002909003,0.000001080258,0.000006659188,0.0004008418,0.9815623,0.0004185118],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004103998,0.9923349,0.00004466214,0.0004766863,0.0004900024,0.005424765,0.00021828,0.0001292057,0.0008404696],"genre_scores_gemma":[0.000004964672,0.985557,0.001116535,0.0002314558,0.001111293,0.001829989,0.0003163728,0.0001477331,0.009684678],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9822363,"threshold_uncertainty_score":0.9997051,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4322617905","doi":"10.2217/imt-2022-0210","title":"Antithymocyte Globulin for Aplastic Anemia Secondary to Pembrolizumab: A Case Report and Review of Literature","year":2023,"lang":"en","type":"review","venue":"Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"","keywords":"Aplastic anemia; Medicine; Pembrolizumab; Anemia; Immunology; Globulin; Immunotherapy; Internal medicine; Immune system; Gastroenterology; Bone marrow","authors":[{"name":"Cynthia Yeung","is_ca":true},{"name":"Nicole Relke","is_ca":true},{"name":"David Good","is_ca":true},{"name":"Natasha Satkunam","is_ca":true},{"name":"Mihaela Mates","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03739182895557941,"gpt":0.3728252956821091,"spread":0.3354334667265297,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000859635,0.0006541603,0.00315835,0.0003895793,0.00009566807,0.00005136182,0.0002000024,0.0004451941,0.0001402998],"category_scores_gemma":[0.0002170182,0.0004894575,0.001061731,0.00102827,0.0001120624,0.00006748101,0.00005144868,0.0004516676,0.00001636975],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001917149,"about_ca_system_score_gemma":0.0009992389,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006682931,"about_ca_topic_score_gemma":0.00001084134,"domain_scores_codex":[0.9968284,0.0001038674,0.001652845,0.0007284386,0.0002880041,0.0003984905],"domain_scores_gemma":[0.9974239,0.0003728504,0.0007623617,0.001026475,0.0002682648,0.0001461535],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0009995212,0.00004530466,5.927865e-7,0.3029168,0.0008893071,0.01243114,0.00009807118,1.125213e-8,0.00003299959,0.00001576011,0.006407098,0.6761634],"study_design_scores_gemma":[0.001489945,0.0005292821,0.000004597139,0.2452932,0.0006830289,0.1049626,0.000006467305,5.061201e-7,0.000006799492,0.000006728309,0.6467198,0.0002970596],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00006409674,0.9933587,0.00008188449,0.0002253478,0.0005524901,0.004748209,0.0007343488,0.0001000349,0.000134876],"genre_scores_gemma":[0.000001802978,0.9935279,0.0007762878,0.001138401,0.0002934997,0.0005868529,0.0006053332,0.0001986292,0.002871311],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6758664,"threshold_uncertainty_score":0.9997557,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2513976653","doi":"10.2217/imt-2016-0070","title":"Controlling Inflammation: A Superior Way to Control TB","year":2016,"lang":"en","type":"editorial","venue":"Immunotherapy","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Tuberculosis; Medicine; Human immunodeficiency virus (HIV); MEDLINE; Mycobacterium tuberculosis; Family medicine; Library science; Internal medicine; Pathology; Computer science; Biology","authors":[{"name":"Nancy Gupta","is_ca":true},{"name":"Babita Agrawal","is_ca":true},{"name":"Rakesh Kumar","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01192464604605101,"gpt":0.3318239860897753,"spread":0.3198993400437243,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001228441,0.0004441457,0.001489285,0.0003078648,0.0001245541,0.00005859986,0.00034638,0.001042092,0.0008127377],"category_scores_gemma":[0.003355187,0.0002942104,0.0004122899,0.0001392453,0.0001089334,0.00008813772,0.00003209005,0.0008641113,0.001353916],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003389901,"about_ca_system_score_gemma":0.0004677781,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002192261,"about_ca_topic_score_gemma":0.00003308992,"domain_scores_codex":[0.9967195,0.0003115869,0.0007814817,0.000565428,0.0007871943,0.0008347663],"domain_scores_gemma":[0.9955862,0.002480675,0.0001678909,0.0008307903,0.000602325,0.0003321328],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.005600163,0.00003639986,0.0000940338,0.00005610822,0.0008181761,0.00004737446,0.0001354906,0.000002555161,0.04596525,0.00008278186,0.9051831,0.04197859],"study_design_scores_gemma":[0.01140032,0.00101936,0.0002802051,0.0003822812,0.00005735168,0.00001056875,0.000008882081,0.00004701325,0.0004217458,0.00007323107,0.9859971,0.0003019343],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.006470504,0.008184866,0.003393671,0.03859255,0.9376054,0.003091483,0.0004757016,0.000296085,0.001889704],"genre_scores_gemma":[0.004533784,0.003705371,0.0002841507,0.00271558,0.9819423,0.0005634277,0.0001883172,0.0001486022,0.005918449],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.08081403,"threshold_uncertainty_score":0.999951,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2804640215","doi":"10.2217/imt-2018-0003","title":"Ragweed Sublingual Tablet Immunotherapy: Part II – Practical Considerations and Pertinent Issues","year":2018,"lang":"en","type":"review","venue":"Immunotherapy","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Ragweed; Sublingual immunotherapy; Medicine; Slit; Allergy; Clinical trial; Dermatology; Immunotherapy; Allergic asthma; Asthma; Allergen immunotherapy; Intensive care medicine; Allergen; Immunology; Internal medicine; Immune system","authors":[{"name":"Oliver Pfaar","is_ca":false},{"name":"Peter S. Creticos","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08254104935116863,"gpt":0.3923671133085607,"spread":0.3098260639573921,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005284791,0.0006021748,0.001918432,0.0002139396,0.0005353271,0.0001944902,0.00006632976,0.0005111442,0.001609443],"category_scores_gemma":[0.0002684002,0.0004585527,0.0003808125,0.0002122597,0.0003016759,0.0001625458,0.00005288335,0.0005171556,0.00009934095],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001096201,"about_ca_system_score_gemma":0.0007439717,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007799111,"about_ca_topic_score_gemma":0.000007068981,"domain_scores_codex":[0.9972145,0.0002921828,0.001066457,0.0006094817,0.0004015463,0.0004158536],"domain_scores_gemma":[0.9980223,0.000318889,0.0004834521,0.0006989953,0.0003496555,0.0001266849],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005128244,0.00104944,0.000009125016,0.003081832,0.003937453,0.0005375198,0.004258959,5.015421e-7,0.0001855492,0.006655185,0.1009606,0.878811],"study_design_scores_gemma":[0.001534949,0.000624306,0.000008561873,0.00375035,0.0003247141,0.002391458,0.00005903183,0.00004177028,0.00001244367,0.0001479851,0.9906632,0.0004412699],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003849305,0.9931958,0.00007731376,0.003162093,0.0006395617,0.001370825,0.00003749403,0.0001474879,0.0009845042],"genre_scores_gemma":[0.00004429496,0.988726,0.002011036,0.001420422,0.001694594,0.00009492167,0.0004378693,0.0001619105,0.00540897],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8897026,"threshold_uncertainty_score":0.9997866,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4407081442","doi":"10.1080/1750743x.2025.2455922","title":"Exploring the role of immunotherapy in the management of follicular cell-derived thyroid cancer","year":2025,"lang":"en","type":"review","venue":"Immunotherapy","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Cancer immunotherapy; Immunotherapy; Thyroid cancer; Follicular phase; Medicine; Follicular cell; Cancer research; Follicular thyroid cancer; Thyroid; Oncology; Immunology; Cancer; Internal medicine; Papillary thyroid cancer","authors":[{"name":"Omar Abdel‐Rahman","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04647064221397133,"gpt":0.326399704560524,"spread":0.2799290623465527,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003912447,0.0004889751,0.001708611,0.0002012837,0.00007208337,0.00002012911,0.0006795372,0.0001105751,0.00005870276],"category_scores_gemma":[0.000001911655,0.0002453381,0.0009594981,0.0007263238,0.0001000495,0.00005170779,0.00005153036,0.0003305365,0.000004396213],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002359332,"about_ca_system_score_gemma":0.0002441115,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007285138,"about_ca_topic_score_gemma":0.00001760825,"domain_scores_codex":[0.9977214,0.0002337126,0.0009209958,0.0003688114,0.0004416823,0.0003133426],"domain_scores_gemma":[0.9978275,0.0002532873,0.0005167292,0.001321095,0.00006089947,0.00002049836],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001304362,0.0005556905,0.00004104105,0.006276779,0.00239283,0.00001632353,0.001234309,0.000005077378,0.0002690526,0.0004962707,0.00004786822,0.9885343],"study_design_scores_gemma":[0.002818149,0.0002957475,0.0007535291,0.03244126,0.001229981,0.000006283053,0.0008515578,0.000001005416,0.001688285,0.0000614249,0.9596089,0.0002438743],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00272792,0.9925004,0.000006597438,0.0001857582,0.0002331088,0.002987147,0.00004698904,0.00001699721,0.001295097],"genre_scores_gemma":[0.002224976,0.9923413,0.0001057941,0.0001577207,0.0000626303,0.004793469,0.00002787928,0.00006602625,0.0002202138],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9882904,"threshold_uncertainty_score":0.9999999,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4403247213","doi":"10.1080/1750743x.2024.2408216","title":"Breaking the mold: nontraditional approaches to allergen immunotherapy for environmental allergens","year":2024,"lang":"en","type":"review","venue":"Immunotherapy","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University; University of Toronto; Kingston Health Sciences Centre; University of Ottawa","funders":"","keywords":"Medicine; Immunotherapy; Allergen immunotherapy; Omalizumab; Desensitization (medicine); Allergen; Immunology; Dosing; Allergy; Intensive care medicine; Immunoglobulin E; Immune system; Internal medicine; Antibody","authors":[{"name":"Rashi Ramchandani","is_ca":true},{"name":"Rachel Lucyshyn","is_ca":true},{"name":"Sophia Linton","is_ca":true},{"name":"Anne K. Ellis","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1560110096589077,"gpt":0.3240526827005774,"spread":0.1680416730416697,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004100034,0.0007294466,0.001475754,0.000224559,0.0003103339,0.0001266573,0.0003552284,0.000386913,0.0004734161],"category_scores_gemma":[0.00001052775,0.0004526164,0.001336806,0.0002360808,0.0001063757,0.00006425243,0.00004432272,0.0004648862,0.0003167647],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000345391,"about_ca_system_score_gemma":0.0002534212,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001166381,"about_ca_topic_score_gemma":0.000004465901,"domain_scores_codex":[0.9973033,0.0001214729,0.0008923456,0.000719263,0.0004743274,0.0004892786],"domain_scores_gemma":[0.9986637,0.0001974011,0.0002473273,0.0007580662,0.00002413801,0.0001094162],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001709105,0.0001770705,4.045401e-7,0.001084661,0.002928859,0.00002504457,0.0008157498,0.00000995412,0.00006858413,0.002631453,0.008245992,0.9838413],"study_design_scores_gemma":[0.0007784863,0.0002691797,0.00002288299,0.002519632,0.0005049279,0.0004496457,0.00007419259,0.0002222598,0.000003399476,0.0001707907,0.9945056,0.0004789403],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003329968,0.9894767,0.002473582,0.001356496,0.0008912542,0.004011978,0.0004172837,0.0001170406,0.001222383],"genre_scores_gemma":[0.00008233951,0.9866664,0.001366475,0.001289577,0.001301627,0.001173152,0.00174243,0.0003315759,0.0060464],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9862597,"threshold_uncertainty_score":0.9997926,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4383872841","doi":"10.2217/imt-2022-0257","title":"An Assessment of Extended Pembrolizumab Dosing in Advanced Non-Small-Cell Lung Cancer in the Covid-19 Pandemic","year":2023,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University; Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Pembrolizumab; Medicine; Dosing; Lung cancer; Adverse effect; Internal medicine; Cancer; Retrospective cohort study; Toxicity; Gastroenterology; Immunotherapy","authors":[{"name":"Gordon Taylor Moffat","is_ca":true},{"name":"Lilian Hanna","is_ca":true},{"name":"Wilma M. Hopman","is_ca":true},{"name":"Andrea S. Fung","is_ca":true},{"name":"Pierre-Olivier Gaudreau","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03164804547800199,"gpt":0.4021801051586452,"spread":0.3705320596806432,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001172373,0.0002294195,0.0004310407,0.000368192,0.0000774697,0.0000263513,0.0003384469,0.0001273977,0.0001749393],"category_scores_gemma":[0.00001396402,0.0001693386,0.0001396321,0.001111513,0.00009807705,0.0001147888,0.0000170857,0.0003329018,0.000001651178],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006190879,"about_ca_system_score_gemma":0.0007984939,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00256555,"about_ca_topic_score_gemma":0.001033674,"domain_scores_codex":[0.998121,0.0002086595,0.0005651593,0.0003525857,0.0003370692,0.0004155627],"domain_scores_gemma":[0.9988889,0.0002017195,0.0001893814,0.0006176393,0.00004084757,0.00006156445],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.003909305,0.0004442687,0.3135729,0.0002228141,0.0001003298,0.00005818244,0.007432963,0.0009770127,0.6261491,0.00003142983,0.0001239348,0.04697775],"study_design_scores_gemma":[0.02515236,0.0006465251,0.9567444,0.0003222473,0.00003347249,0.00003872848,0.002547935,0.007554808,0.002845919,0.00008120407,0.003719788,0.0003126346],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9921099,0.004655593,0.0003318531,0.001043367,0.0002204722,0.001148154,0.00001976586,0.00007480153,0.0003960878],"genre_scores_gemma":[0.9871855,0.009228584,0.000257502,0.002725329,0.00005391304,0.0003106985,0.00002909961,0.00004538123,0.0001639328],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6431714,"threshold_uncertainty_score":0.6905428,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4405200272","doi":"10.1080/1750743x.2024.2436838","title":"Musculoskeletal immune-related adverse events of PD-(L)1 inhibitors in melanoma: a systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta; Research Canada; Dalhousie University","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health; American Academy of Allergy Asthma and Immunology","keywords":"Adverse effect; Medicine; Immune system; Melanoma; Pembrolizumab; Incidence (geometry); Meta-analysis; Oncology; Ipilimumab; Internal medicine; Immunotherapy; Immunology; Cancer research","authors":[{"name":"Janet Roberts","is_ca":true},{"name":"Sara Barmettler","is_ca":false},{"name":"Jenna Murray","is_ca":false},{"name":"Jennifer E. Melvin","is_ca":true},{"name":"Carrie Ye","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03227925669359021,"gpt":0.3540401153066937,"spread":0.3217608586131034,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.001926628,0.0009728788,0.01461714,0.001358185,0.00003963969,0.0000133767,0.0003480651,0.0005181087,0.0005859232],"category_scores_gemma":[0.00006171026,0.000587514,0.01097246,0.003220025,0.0001606745,0.00009688615,0.00007490842,0.0006930108,0.00005537656],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002913307,"about_ca_system_score_gemma":0.0003072262,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002528082,"about_ca_topic_score_gemma":0.00002138213,"domain_scores_codex":[0.993595,0.0007127228,0.004021815,0.0007550704,0.0005284726,0.0003869172],"domain_scores_gemma":[0.9968201,0.0001926839,0.001500187,0.001309348,0.00009694297,0.00008077289],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00004865154,0.0001186693,0.000001723464,0.652312,0.3415019,0.00003530945,0.0001096466,7.73574e-8,0.000007351342,0.00001532598,0.000030254,0.005819112],"study_design_scores_gemma":[0.0008916709,0.0002081424,0.000009894321,0.1481135,0.8225788,0.0001464855,0.00002754125,0.000001986397,0.000001598058,0.00001007734,0.02755729,0.0004529974],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00005051981,0.9934629,0.000002289606,0.0001584415,0.0001608934,0.005872201,0.0001220302,0.00005892701,0.0001118],"genre_scores_gemma":[0.000184655,0.9960151,0.00004464896,0.0001599218,0.00001688479,0.0009629939,0.0001692736,0.0001394031,0.002307061],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.5041985,"threshold_uncertainty_score":0.9996576,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4405111359","doi":"10.1080/1750743x.2024.2436346","title":"Concurrent immunotherapy and radiation in cisplatin-ineligible patients with HNSCC: a systematic review &amp; meta-analysis","year":2024,"lang":"en","type":"review","venue":"Immunotherapy","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Juravinski Cancer Centre; McMaster University","funders":"","keywords":"Medicine; Radiosensitizer; Oncology; Cisplatin; Head and neck squamous-cell carcinoma; Immunotherapy; Meta-analysis; Internal medicine; Radiation therapy; Standard of care; Head and neck cancer; Chemotherapy; Cancer","authors":[{"name":"Sze Wah Samuel Chan","is_ca":true},{"name":"Zainab Al Maqrashi","is_ca":true},{"name":"Jack Young","is_ca":true},{"name":"Do-Hoon Kim","is_ca":true},{"name":"Gregory R. Pond","is_ca":true},{"name":"Brandon M. Meyers","is_ca":true},{"name":"Adi Kartolo","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07829244723347409,"gpt":0.3949451119656623,"spread":0.3166526647321882,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007796852,0.0008622743,0.0117806,0.0007723243,0.00006978498,0.00007653241,0.0001828731,0.0002003232,0.000182391],"category_scores_gemma":[0.00004854151,0.0004552623,0.00220724,0.001934344,0.00007991778,0.00008422906,0.00003252609,0.0005131238,0.00008416941],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002904229,"about_ca_system_score_gemma":0.000242705,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008258654,"about_ca_topic_score_gemma":0.00005047408,"domain_scores_codex":[0.9961327,0.0004010117,0.001798285,0.0007194679,0.000581082,0.0003675091],"domain_scores_gemma":[0.9978801,0.0002478565,0.0007256334,0.0009144489,0.000151532,0.00008041519],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002745929,0.0001416959,0.00003292811,0.6869547,0.192657,0.000008413959,0.0002824969,1.43225e-7,1.42686e-7,0.00002551158,0.0003512122,0.1195184],"study_design_scores_gemma":[0.00116042,0.0002026821,0.00002818431,0.2046091,0.3824627,0.00001426659,0.000004714722,0.000002369399,6.788661e-8,0.000003073088,0.4111161,0.0003963596],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001641959,0.9935513,0.00003380264,0.0001765583,0.0001390817,0.005808221,0.0001100354,0.00006483154,0.00009981736],"genre_scores_gemma":[0.00003430762,0.9955425,0.00007223131,0.0006964257,0.00003766525,0.002221185,0.0003614312,0.0001232815,0.0009109369],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.4823456,"threshold_uncertainty_score":0.9997899,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4391882558","doi":"10.2217/imt-2023-0293","title":"Upadacitinib for the Treatment of Moderate-to-Severe Crohn’s Disease","year":2024,"lang":"en","type":"review","venue":"Immunotherapy","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University; University of Calgary","funders":"","keywords":"Medicine; Rheumatoid arthritis; Crohn's disease; Internal medicine; Janus kinase; Disease; Oncology; Malignancy; Cytokine","authors":[{"name":"Jurij Hanžel","is_ca":false},{"name":"Christopher Ma","is_ca":true},{"name":"Vipul Jairath","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02976364088780458,"gpt":0.3346496295131636,"spread":0.304885988625359,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008889708,0.0004459407,0.0005887242,0.00005811621,0.00008804561,0.00005431743,0.0003559479,0.0001771523,0.00002931776],"category_scores_gemma":[0.0000163486,0.0002604549,0.001099273,0.00007243757,0.00006549827,0.000001756714,0.00003138492,0.00005507145,0.00004753203],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006075158,"about_ca_system_score_gemma":0.0005319996,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005165929,"about_ca_topic_score_gemma":0.00000550624,"domain_scores_codex":[0.9986992,0.0000701684,0.0004165175,0.0004468656,0.0001140668,0.0002531882],"domain_scores_gemma":[0.9987185,0.00004203773,0.0001390576,0.0009277625,0.00007325365,0.0000993664],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00147905,0.0001961415,0.000001552194,0.003781246,0.001647357,0.00005783089,0.00008466682,0.00003070818,0.0000606383,0.0002615236,0.002903548,0.9894958],"study_design_scores_gemma":[0.000519663,0.0001947308,0.00004012744,0.0007685706,0.0007952346,0.000003917374,0.000005816473,0.00002055285,0.00002820604,0.00004696715,0.9972808,0.0002953582],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004258277,0.9947219,0.0002794257,0.00003702213,0.0003960135,0.002633445,0.001434296,0.00001776142,0.00005423577],"genre_scores_gemma":[0.0000822382,0.992678,0.00009372706,0.0001240266,0.0004322935,0.002088812,0.0004382454,0.0001362643,0.003926366],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9943773,"threshold_uncertainty_score":0.9999847,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4411260891","doi":"10.1080/1750743x.2025.2518913","title":"Time toxicity of nivolumab in metastatic head and neck squamous cell carcinoma patients: a single-institution experience","year":2025,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Hamilton Health Sciences; Population Health Research Institute; McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Nivolumab; Medicine; Head and neck; Toxicity; Basal cell; Oncology; Head and neck squamous-cell carcinoma; Radiation therapy; Internal medicine; Carcinoma; Head and neck cancer; Surgery; Cancer; Immunotherapy","authors":[{"name":"Michelle Bradbury","is_ca":true},{"name":"Adam Gabara","is_ca":true},{"name":"Gregory R. Pond","is_ca":true},{"name":"Brandon M. Meyers","is_ca":true},{"name":"Adi Kartolo","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01306248268983103,"gpt":0.2701643034079915,"spread":0.2571018207181605,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001216672,0.0001613217,0.0003477508,0.0001976856,0.000052381,0.00001440701,0.0000895707,0.00006428218,0.00008069468],"category_scores_gemma":[0.00002588845,0.0001446105,0.00008395285,0.00038745,0.0002417091,0.0001162402,0.00001873593,0.00009780186,0.000003015882],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001908046,"about_ca_system_score_gemma":0.0001257644,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006269065,"about_ca_topic_score_gemma":0.00005325268,"domain_scores_codex":[0.9989254,0.00005414467,0.0004169072,0.0002404156,0.0001627391,0.0002003818],"domain_scores_gemma":[0.9994504,0.00005386159,0.0001094873,0.0002860582,0.00007144832,0.00002869949],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.009619029,0.002403673,0.1211159,0.0002842371,0.00007554504,0.00001542248,0.00551717,0.000006329567,0.8080187,0.00006466608,0.0001601826,0.05271912],"study_design_scores_gemma":[0.03632231,0.003378743,0.6431766,0.0004954142,0.00005612476,0.0000146663,0.0007005959,0.0005591994,0.3085635,0.00007908118,0.006277989,0.0003757212],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929902,0.004855794,0.0001186978,0.0001347304,0.0001327411,0.0005368319,0.00001016222,0.00002388994,0.001196932],"genre_scores_gemma":[0.9983221,0.000134207,0.0003862734,0.0005703162,0.000008872521,0.00003126183,0.00001041784,0.00001258527,0.0005239721],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5220607,"threshold_uncertainty_score":0.5897044,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2069156224","doi":"10.2217/imt.12.27","title":"Research Highlights: Highlights from the Latest Articles in Immunotherapy","year":2012,"lang":"en","type":"letter","venue":"Immunotherapy","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Lawson Health Research Institute; Western University","funders":"","keywords":"Flora (microbiology); Immunology; Immune system; Autoimmunity; Disease; Gut flora; Biology; Nod; Microbiology; Medicine; Diabetes mellitus; Bacteria; Internal medicine; Genetics","authors":[{"name":"Kelly L. Summers","is_ca":true},{"name":"Bhagirath Singh","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03316066186204686,"gpt":0.3149871282129649,"spread":0.2818264663509181,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.000991341,0.0005030131,0.0004730295,0.0001713058,0.0003400675,0.0001570666,0.001225239,0.001420664,0.0003207505],"category_scores_gemma":[0.00001765423,0.0003431988,0.0002281179,0.0003223799,0.0003513072,0.00001101319,0.0001317239,0.001948723,0.0003797797],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000123978,"about_ca_system_score_gemma":0.0003330384,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003138693,"about_ca_topic_score_gemma":0.000526296,"domain_scores_codex":[0.9961264,0.0008827922,0.0006016732,0.0007328081,0.0004365355,0.001219843],"domain_scores_gemma":[0.9976494,0.0002573545,0.0001933775,0.001681689,0.0001603671,0.00005779348],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001825842,0.00009690673,0.000355034,0.00001342076,0.0001665817,0.00002165923,0.0005601393,8.11981e-7,0.3916046,0.00009872109,0.6057488,0.001150687],"study_design_scores_gemma":[0.001207252,0.0001871603,0.008389307,0.00009208865,0.000007969667,0.00001172292,0.00004961722,9.161679e-7,0.01878344,0.0002658974,0.9705806,0.0004240516],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.2213551,0.06615256,0.00002428707,0.7090917,0.001200858,0.001045622,0.0002015182,0.00004562525,0.000882723],"genre_scores_gemma":[0.1506398,0.05917059,0.0005172816,0.7580351,0.01720861,0.0003737606,0.003127236,0.0005186506,0.01040892],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.3728212,"threshold_uncertainty_score":0.999902,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4407377433","doi":"10.1080/1750743x.2025.2457931","title":"Benralizumab in severe eosinophilic asthma by biologic use and key clinical subgroups: real-world XALOC-1 programme: a plain language summary of publication","year":2025,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"AstraZeneca (Canada)","funders":"McGill University; McMaster University; AstraZeneca","keywords":"Benralizumab; Asthma; Medicine; Eosinophilic; Internal medicine; Pathology; Eosinophil; Mepolizumab","authors":[{"name":"David J. Jackson","is_ca":false},{"name":"Girolamo Pelaia","is_ca":false},{"name":"Benjamin Emmanuel","is_ca":false},{"name":"Trung N. Tran","is_ca":false},{"name":"David Cohen","is_ca":false},{"name":"Vivian H. Shih","is_ca":false},{"name":"Anat Shavit","is_ca":false},{"name":"Douglas Arbetter","is_ca":false},{"name":"Rohit Katial","is_ca":false},{"name":"Adrian Rabe","is_ca":false},{"name":"Esther García Gil","is_ca":false},{"name":"Marisa Pardal","is_ca":false},{"name":"Javier Nuevo","is_ca":false},{"name":"Michael Watt","is_ca":false},{"name":"Silvia Boarino","is_ca":false},{"name":"Sheena Kayaniyil","is_ca":true},{"name":"Alicia Padilla‐Galo","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0220841725104322,"gpt":0.3304853682888036,"spread":0.3084011957783714,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003334391,0.000173024,0.0004274616,0.0002559535,0.00004424058,0.00003876608,0.0001191281,0.0001662963,0.00004571103],"category_scores_gemma":[0.0001725568,0.0001337009,0.0001143319,0.000512635,0.0002329905,0.0001407354,0.00003545623,0.0002098325,0.000003410624],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006183206,"about_ca_system_score_gemma":0.0001591714,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007340434,"about_ca_topic_score_gemma":0.0002678491,"domain_scores_codex":[0.9984887,0.0002170151,0.0005871271,0.0003244448,0.0001324795,0.0002502557],"domain_scores_gemma":[0.9990382,0.0002253007,0.0001567366,0.0004058509,0.00009358225,0.00008035011],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001580112,0.001038115,0.7187656,0.0001159919,0.0001129851,0.000024191,0.0003372707,3.286478e-7,0.01300373,0.000828394,0.004883754,0.2593096],"study_design_scores_gemma":[0.005080309,0.0007390906,0.9065824,0.0002813306,0.00002277644,0.000006994083,0.0003159143,0.00005158655,0.0007139021,0.00007225842,0.08596072,0.0001727516],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9875987,0.009904671,0.00001927684,0.001090087,0.00006543667,0.0006740577,0.00005537197,0.00007233636,0.0005200466],"genre_scores_gemma":[0.9929935,0.002681574,0.0002578707,0.001609833,0.00004404721,0.00006692055,0.0002495166,0.00002122109,0.002075501],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2591368,"threshold_uncertainty_score":0.5452166,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4389951978","doi":"10.2217/imt-2023-0201","title":"Epicutaneous Immunotherapy with Viaskin Peanut in toddlers: a plain language summary","year":2023,"lang":"en","type":"letter","venue":"Immunotherapy","topic":"Food Allergy and Anaphylaxis Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"Genentech; UnitedHealth Group; Thermo Fisher Scientific; Food Allergy Research and Education","keywords":"Immunotherapy; Oral immunotherapy; Medicine; Psychology; Immunology; Immune system","authors":[{"name":"David R. Stukus","is_ca":false},{"name":"Ruchi S. Gupta","is_ca":false},{"name":"Douglas P. Mack","is_ca":true},{"name":"Lianne Mandelbaum","is_ca":false},{"name":"Dareen Siri","is_ca":false},{"name":"Vivian Hernandez‐Trujillo","is_ca":false},{"name":"Hugh A. Sampson","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01674315307908023,"gpt":0.2877756399452742,"spread":0.271032486866194,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0004695422,0.0007755351,0.001187779,0.001060205,0.0001280368,0.0001147386,0.0006432968,0.001089294,0.0008455325],"category_scores_gemma":[0.00003804086,0.0006072018,0.0003855199,0.001003967,0.0002932305,0.0001028656,0.00006013078,0.003990155,0.0004709763],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000355968,"about_ca_system_score_gemma":0.0004415186,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001493787,"about_ca_topic_score_gemma":0.0005305706,"domain_scores_codex":[0.9958029,0.0002964956,0.0006563297,0.0008939553,0.001128135,0.001222125],"domain_scores_gemma":[0.9978318,0.0004371147,0.0001996251,0.001332426,0.0001061382,0.00009291882],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.006564129,0.0004472813,0.0003114507,0.0006165438,0.002202671,0.06701543,0.004240864,0.00002030769,0.01063644,0.00002654079,0.8197581,0.08816022],"study_design_scores_gemma":[0.005719182,0.002297763,0.001079418,0.001632593,0.000009326793,0.0007447281,0.0004390256,0.00005376413,0.0005029453,0.00005612744,0.9866583,0.0008068437],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.1282981,0.04366573,0.00007404653,0.8057379,0.00110391,0.004323066,0.0002922213,0.001318304,0.01518671],"genre_scores_gemma":[0.01369264,0.02149569,0.0007374812,0.767473,0.005824224,0.0007012617,0.003017719,0.001371731,0.1856863],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.1704995,"threshold_uncertainty_score":0.999638,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4409178690","doi":"10.1080/1750743x.2025.2485012","title":"Effects of cannabinoids on immune checkpoint inhibitor response: CCTG pooled analysis of individual patient data","year":2025,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Calgary; Princess Margaret Cancer Centre; McMaster University; Pancreas Centre (Canada); University Health Network; Kingston Health Sciences Centre; Canadian Partnership Against Cancer","funders":"Canadian Cancer Society Research Institute; AstraZeneca","keywords":"Immune system; Medicine; Immunology; Oncology; Cancer research","authors":[{"name":"Courtney H. Coschi","is_ca":true},{"name":"Keyue Ding","is_ca":true},{"name":"Justin Tong","is_ca":true},{"name":"Dongsheng Tu","is_ca":true},{"name":"Christopher O’Callaghan","is_ca":true},{"name":"Natasha B. Leighl","is_ca":true},{"name":"Francisco Vera-Badillo","is_ca":false},{"name":"Rosalyn A. Juergens","is_ca":true},{"name":"Desirée Hao","is_ca":false},{"name":"Lesley Seymour","is_ca":true},{"name":"Daniel J. Renouf","is_ca":true},{"name":"Eric X. Chen","is_ca":true},{"name":"Pierre-Olivier Gaudreau","is_ca":true},{"name":"Andrea S. Fung","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01206976354950515,"gpt":0.2952771858467567,"spread":0.2832074222972515,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009790375,0.0002728481,0.0009430433,0.001025811,0.00006242008,0.0000164911,0.0005383129,0.0001714846,0.000116994],"category_scores_gemma":[0.000192241,0.0002247218,0.0004669237,0.002180935,0.0002246307,0.00007453616,0.0001285835,0.0002141852,0.00000233829],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001478731,"about_ca_system_score_gemma":0.0003980529,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005498447,"about_ca_topic_score_gemma":0.00001799197,"domain_scores_codex":[0.9975007,0.0002621106,0.0009864919,0.0004282377,0.0005504226,0.0002719964],"domain_scores_gemma":[0.9973598,0.0003790648,0.0004213465,0.001634261,0.0001621468,0.00004343741],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.04366432,0.0009494611,0.0009871456,0.0001739087,0.01418003,0.00001031742,0.001166235,0.000009600095,0.8600155,0.00004859419,0.000692533,0.07810236],"study_design_scores_gemma":[0.006901158,0.001857529,0.3354995,0.0005395888,0.002042664,0.000002148091,0.0001755198,0.00009375143,0.6441413,0.0000112129,0.008563307,0.0001723606],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9840057,0.01335185,0.00009287428,0.0009635772,0.000387814,0.0007891071,0.0002107895,0.00003843765,0.0001598809],"genre_scores_gemma":[0.9973021,0.0007600437,0.0001927338,0.0008204681,0.00002630374,0.00004274231,0.0002081018,0.00002891498,0.0006186105],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3345123,"threshold_uncertainty_score":0.9163889,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2067278548","doi":"10.2217/imt.11.25","title":"Research Highlights: Do Conventional Treatments for HPV-Positive Head and Neck Cancers Elicit Immunotherapeutic Type Responses?","year":2011,"lang":"en","type":"letter","venue":"Immunotherapy","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; HPV vaccines; Cancer; Human papillomavirus; Head and neck cancer; MEDLINE; Family medicine; Oncology; Internal medicine; Cervical cancer; HPV infection; Biology","authors":[{"name":"Hosam A. Kader","is_ca":true},{"name":"Darin A. Wick","is_ca":true},{"name":"John R. Webb","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1097987498157338,"gpt":0.4235713409828063,"spread":0.3137725911670726,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007186154,0.0005402612,0.0009086298,0.0006441777,0.0004345921,0.0001511797,0.0003778413,0.0009236589,0.006465247],"category_scores_gemma":[0.00004738786,0.0004385233,0.00035639,0.0004761577,0.0006221195,0.0001067225,0.00006941551,0.001956089,0.0001565835],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001351722,"about_ca_system_score_gemma":0.001444423,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002284859,"about_ca_topic_score_gemma":0.00004208386,"domain_scores_codex":[0.9958904,0.0004157198,0.0005454708,0.0009182009,0.001113916,0.001116241],"domain_scores_gemma":[0.9967068,0.0008356956,0.0001485199,0.0008617082,0.001292534,0.0001547],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.09686203,0.0006719447,0.000862599,0.000985473,0.009169399,0.0005169002,0.00205103,2.705653e-7,0.005065774,0.001922574,0.7252121,0.1566799],"study_design_scores_gemma":[0.01085174,0.005235076,0.02824752,0.0003014457,0.0001968177,0.00006088021,0.00004992264,0.0000115998,0.001169913,0.001138406,0.9522993,0.0004373509],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.06041685,0.1935633,0.0001667583,0.6806299,0.002938886,0.01589336,0.002090254,0.0003780133,0.04392264],"genre_scores_gemma":[0.02983827,0.09489745,0.001670733,0.6335588,0.01062881,0.004380688,0.003650575,0.00122738,0.2201474],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.2270873,"threshold_uncertainty_score":0.9998066,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4410303297","doi":"10.1080/1750743x.2025.2493039","title":"Assessing real-world treatment with SDZ ETN (an etanercept biosimilar) in people with rheumatic diseases included in the COMPACT study: a plain language summary","year":2025,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Medac; Cilag; Mylan; Celgene; Biogen; Gilead Sciences; Chugai Pharmaceutical; Celltrion; Sanofi; Eli Lilly and Company; AstraZeneca; Edwards Lifesciences; Amgen","keywords":"Biosimilar; Etanercept; Medicine; Plain language; Pharmacology; Internal medicine; Intensive care medicine; Oncology; Physical therapy; Rheumatoid arthritis; Linguistics","authors":[{"name":"Marc Schmalzing","is_ca":false},{"name":"H Kellner","is_ca":false},{"name":"Ayman Askari","is_ca":false},{"name":"Javier de Toro Santos","is_ca":false},{"name":"Julio Cesar Vazquez Perez-Coleman","is_ca":false},{"name":"Rosario Foti","is_ca":false},{"name":"Sławomir Jeka","is_ca":false},{"name":"Yannick Allanore","is_ca":false},{"name":"P. Peichl","is_ca":false},{"name":"Martin Oehri","is_ca":false},{"name":"Neil Betteridge","is_ca":false},{"name":"Cristofer Salvati","is_ca":false},{"name":"Elisa Isabel Sánchez-Romero","is_ca":false},{"name":"Ines Brueckmann","is_ca":false},{"name":"Tom Sheeran","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02248146023747329,"gpt":0.3565027595321673,"spread":0.334021299294694,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006166148,0.0003435063,0.000655392,0.0003348616,0.000198276,0.0001178933,0.0003756654,0.0001222284,0.000137519],"category_scores_gemma":[0.00001522376,0.0001747836,0.00007398703,0.0009385985,0.0002193575,0.0001659757,0.00002661186,0.0003349062,0.000003924824],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002077492,"about_ca_system_score_gemma":0.0001721222,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006525782,"about_ca_topic_score_gemma":0.04162815,"domain_scores_codex":[0.9972142,0.001474513,0.0004065815,0.0004046139,0.00008234615,0.0004177534],"domain_scores_gemma":[0.9985458,0.0006675157,0.0001145776,0.0006256286,0.00002510858,0.00002135678],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00484022,0.008751292,0.8591805,0.00006150122,0.001321097,0.0001965957,0.02629113,0.00003874691,0.01972882,0.0004772983,0.000291354,0.07882151],"study_design_scores_gemma":[0.007919597,0.002181235,0.9666438,0.0003546918,0.0001406605,0.00001521574,0.0197852,0.00007198228,0.001225805,0.00006663934,0.001264404,0.0003308244],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9931316,0.00278232,0.00006636739,0.001382366,0.0000707864,0.001047174,0.00002617853,0.00005848519,0.001434773],"genre_scores_gemma":[0.9974996,0.0003458299,0.0002621873,0.0009272581,0.000008791638,0.00009521981,0.00005449027,0.00002432408,0.0007822963],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1074633,"threshold_uncertainty_score":0.9865074,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4413876847","doi":"10.1080/1750743x.2025.2545172","title":"Amlitelimab, an anti-OX40 ligand antibody, for atopic dermatitis: a plain language summary of STREAM-AD clinical study","year":2025,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Association of Cardiovascular Prevention and Rehabilitation; Probity Medical Research","funders":"","keywords":"Atopic dermatitis; Medicine; Antibody; Immunology; Dermatology","authors":[{"name":"Stephan Weidinger","is_ca":false},{"name":"Andrew Blauvelt","is_ca":false},{"name":"Kim Papp","is_ca":true},{"name":"Adam Reich","is_ca":false},{"name":"Chih‐Hung Lee","is_ca":false},{"name":"Margitta Worm","is_ca":false},{"name":"Charles Lynde","is_ca":true},{"name":"Yoko Kataoka","is_ca":false},{"name":"Peter Foley","is_ca":false},{"name":"Xiaodan Wei","is_ca":false},{"name":"Anne-Catherine Solente","is_ca":false},{"name":"Christine Weber","is_ca":false},{"name":"Samuel Adelman","is_ca":false},{"name":"Sonya Davey","is_ca":false},{"name":"Fabrice Hurbin","is_ca":false},{"name":"Natalie Rynkiewicz","is_ca":false},{"name":"Karl Yen","is_ca":false},{"name":"John T. O’Malley","is_ca":false},{"name":"Charlotte Bernigaud","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01741069612282447,"gpt":0.3835217972923066,"spread":0.3661111011694821,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002959416,0.0001693638,0.0005419682,0.0001264216,0.00008814794,0.00001985234,0.0001570407,0.0001084542,0.00002754561],"category_scores_gemma":[0.0000636781,0.0001337379,0.0002005959,0.0001807948,0.0001220884,0.00008226608,0.00002438648,0.0001241311,0.000003479861],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002010595,"about_ca_system_score_gemma":0.0002224095,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006277976,"about_ca_topic_score_gemma":0.00002262825,"domain_scores_codex":[0.998674,0.0001291722,0.000565676,0.0002699021,0.0001579303,0.0002033582],"domain_scores_gemma":[0.9990051,0.0001706967,0.0001251609,0.0005224736,0.0001024665,0.00007409426],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0008115522,0.004733035,0.6816909,0.0003035231,0.0006029744,0.0001018546,0.001772537,0.000001295084,0.02732023,0.000109934,0.0009212282,0.281631],"study_design_scores_gemma":[0.01104091,0.002403665,0.9521655,0.0003775723,0.0001563465,0.000006256467,0.004138444,0.00011027,0.005117996,0.00004350072,0.02425666,0.000182897],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9861466,0.0115872,0.0003685459,0.0002098422,0.0002099912,0.00113244,0.00007627359,0.00007007884,0.000199044],"genre_scores_gemma":[0.9968178,0.0005902151,0.0002486068,0.001446143,0.00009425116,0.00004268071,0.00007623338,0.00002672772,0.0006573636],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2814481,"threshold_uncertainty_score":0.5453675,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4415765951","doi":"10.1080/1750743x.2025.2578164","title":"Effects of serotonergic drugs on immune checkpoint inhibitor response: a pooled analysis of individual patient data from four Canadian Cancer Trials Group (CCTG) trials","year":2025,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Calgary; Pancreas Centre (Canada); Queen's University; McMaster University; Juravinski Cancer Centre; Occupational Cancer Research Centre; Princess Margaret Cancer Centre","funders":"Canadian Cancer Society Research Institute; AstraZeneca","keywords":"Serotonergic; Pooled analysis; Context (archaeology); Clinical trial; Meta-analysis; Patient data; Cancer; Immune system","authors":[{"name":"Courtney H. Coschi","is_ca":true},{"name":"Keyue Ding","is_ca":true},{"name":"Dongsheng Tu","is_ca":true},{"name":"Christopher O’Callaghan","is_ca":true},{"name":"Natasha B. Leighl","is_ca":true},{"name":"Francisco Vera-Badillo","is_ca":false},{"name":"Rosalyn A. Juergens","is_ca":true},{"name":"Desirée Hao","is_ca":true},{"name":"Lesley Seymour","is_ca":true},{"name":"Daniel J. Renouf","is_ca":true},{"name":"Eric X. Chen","is_ca":true},{"name":"Andrea S. Fung","is_ca":true},{"name":"Pierre-Olivier Gaudreau","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04188281269778614,"gpt":0.3426528544300924,"spread":0.3007700417323063,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006374827,0.0004747268,0.003776747,0.001885799,0.0001211376,0.00005210838,0.0007490991,0.0003215138,0.0004390086],"category_scores_gemma":[0.004398801,0.0003822315,0.001130622,0.001860633,0.0001905728,0.0001190473,0.00009873378,0.000327492,0.000004715563],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004372337,"about_ca_system_score_gemma":0.002018188,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.1969959,"about_ca_topic_score_gemma":0.01147972,"domain_scores_codex":[0.9921398,0.003313745,0.002623241,0.0006703968,0.0007680324,0.0004847875],"domain_scores_gemma":[0.9888316,0.00732747,0.001464464,0.001996612,0.0002162597,0.000163541],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.1000592,0.0007580919,0.001163403,0.0002331559,0.02801071,0.00003742054,0.003302878,0.00004334644,0.736161,0.00002817993,0.001503137,0.1286995],"study_design_scores_gemma":[0.02892916,0.00264293,0.3620339,0.003421411,0.01511996,0.000003473961,0.0008510801,0.0003141489,0.5509484,0.00005151381,0.03506292,0.0006211713],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9517294,0.04194423,0.00002576023,0.001128715,0.0008355962,0.00251417,0.001745945,0.00003584466,0.00004037663],"genre_scores_gemma":[0.9924833,0.004755917,0.00012673,0.0008305486,0.0002462897,0.0003794938,0.0006697822,0.00006184563,0.0004461046],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3608705,"threshold_uncertainty_score":0.999863,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2106760394","doi":"10.2217/imt.09.33","title":"Conference Scene: 3Rd Keystone Symposium On T Regulatory Cells","year":2009,"lang":"en","type":"article","venue":"Immunotherapy","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"T-cell receptor; Biology; Antigen; Immunology; T cell; Immune system","authors":[{"name":"Alicia N. McMurchy","is_ca":true},{"name":"Megan K. Levings","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01104180238505264,"gpt":0.2303903368917766,"spread":0.2193485345067239,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0002422979,0.0004115759,0.0005026653,0.0001737491,0.0003254248,0.00003909448,0.0006008861,0.0005497319,0.00149306],"category_scores_gemma":[0.00000699576,0.0003576312,0.0001970823,0.0001642623,0.0003874296,0.0001081327,0.00003354258,0.0005877408,0.003817886],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007871236,"about_ca_system_score_gemma":0.00009721655,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005388097,"about_ca_topic_score_gemma":0.000003481195,"domain_scores_codex":[0.9979704,0.0002569417,0.0004516826,0.0005542987,0.00007400582,0.000692672],"domain_scores_gemma":[0.9986049,0.00009703488,0.0001927916,0.0009783224,0.0000965073,0.00003043095],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0006696067,0.0004792373,0.00003421709,0.000004156039,0.0001531462,0.00001163701,0.0004130862,0.000007796395,0.9639665,0.006569371,0.005713309,0.02197787],"study_design_scores_gemma":[0.002659502,0.001133763,0.001172665,0.00004408657,0.0000158556,0.00005400803,0.00005915681,0.000003185072,0.823158,0.0004721351,0.1708487,0.0003789226],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9735211,0.00732822,0.0001504457,0.002806139,0.002634644,0.0004319565,0.00002068812,0.000377581,0.01272919],"genre_scores_gemma":[0.966902,0.001439441,0.0001057783,0.003206145,0.00007267049,0.00001791626,0.00005423136,0.00003756356,0.02816423],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1651354,"threshold_uncertainty_score":0.9998876,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}